<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article SYSTEM "http://jats.nlm.nih.gov/publishing/1.1/JATS-journalpublishing1.dtd">
<article article-type="other" dtd-version="1.1" xml:lang="en" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">
    <front>
        <journal-meta>
            <journal-id journal-id-type="publisher-id">CTMC</journal-id>
            <journal-id journal-id-type="nlm-ta">Curr Top Med Chem</journal-id>
            <journal-title-group>
                <journal-title>Current Topics in Medicinal Chemistry</journal-title>
                <abbrev-journal-title abbrev-type="pubmed">Curr. Top. Med. Chem.</abbrev-journal-title>
            </journal-title-group>
            <issn pub-type="ppub">1568-0266</issn>
            <issn pub-type="epub">1873-4294</issn>
            <publisher>
                <publisher-name>Bentham Science Publishers</publisher-name>
            </publisher>
        </journal-meta>
        <article-meta>
            <article-id pub-id-type="publisher-id">CTMC-22-19-1571</article-id>
            <article-id pub-id-type="doi">10.2174/1568026622666220610141243</article-id>
            <article-categories>
                <subj-group subj-group-type="heading">
                    <subject>Pharmaceutical and Medicinal Chemistry</subject>
                </subj-group>
            </article-categories>
            <title-group>
                <article-title>Chemical and Physical Approaches for Improved Biopharmaceutical &#x2028;Activity of Amphotericin B: Current and Future Prospective</article-title>
            </title-group>
            <contrib-group>
                <contrib contrib-type="author">
                    <name>
                        <surname>Mahor</surname>
                        <given-names>Ajay</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff1">1</xref>
                </contrib>
                <contrib contrib-type="author">
                    <name>
                        <surname>Sawant</surname>
                        <given-names>Devesh M.</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff1">1</xref>
                </contrib>
                <contrib contrib-type="author" corresp="yes">
                    <name>
                        <surname>Goyal</surname>
                        <given-names>Amit Kumar</given-names>
                    </name>
                    <xref ref-type="aff" rid="aff1">1</xref>
                    <xref ref-type="corresp" rid="cor1">*</xref>
                </contrib>
                <aff id="aff1">
                    <label>1</label>
                    <institution>Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Bandarsindri, Ajmer</institution>, <country country="in">India</country></aff>
            </contrib-group>
            <author-notes>
                <corresp id="cor1">
                    <label>*</label>Address correspondence to this author at the Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Bandarsindri, Ajmer, India; E-mails: <email xlink:href="amit.goyal@curaj.ac.in">amit.goyal@curaj.ac.in</email>; <email xlink:href="amitkumargoyal1979@gmail.com">amitkumargoyal1979@gmail.com</email></corresp>
            </author-notes>
            <pub-date pub-type="epub">
                <year>2022</year>
            </pub-date>
            <volume>22</volume>
            <issue>19</issue>
            <fpage>1571</fpage>
            <lpage>1592</lpage>
            <history>
                <date date-type="received">
                    <day>03</day>
                    <month>01</month>
                    <year>2022</year>
                </date>
                <date date-type="rev-recd">
                    <day>01</day>
                    <month>03</month>
                    <year>2022</year>
                </date>
                <date date-type="accepted">
                    <day>24</day>
                    <month>03</month>
                    <year>2022</year>
                </date>
            </history>
            <permissions>
                <copyright-year>2022</copyright-year>
                <copyright-holder>Bentham Science Publishers</copyright-holder>
            </permissions>
            <abstract>
                <p>Over the last 50 years, the number of patients with mycotic infections has gradually increased. Amphotericin-B is a gold-standard drug used in serious systemic fungal infections. However, limited solubility and permeability are challenging issues associated with Amphotericin-B. Chemical modification is one of the ways to get its broader applicability and improved physicochemical properties. The review article provides a comprehensive overview of the chemical modification approach for investigating the mechanism of action, biological activity, bioavailability, and toxicity of Amphotericin B. Further, several drug delivery approaches have also been utilized to provide better therapeutic outcomes. This gives an overview of chemical approaches for exploring various factors associated with Amphotericin B and information on its drug delivery approaches for improved biopharmaceutical outcomes.</p>
            </abstract>
            <kwd-group kwd-group-type="author">
                <title>Keywords</title>
                <kwd>Amphotericin-B</kwd>
                <kwd>Fungal infections</kwd>
                <kwd>Chemical modification</kwd>
                <kwd>Drug delivery</kwd>
                <kwd>BCS class IV</kwd>
                <kwd>Bioavailability</kwd>
            </kwd-group>
        </article-meta>
    </front>
    <body>
        <sec id="sec1" sec-type="intro">
            <label>1</label>
            <title>INTRODUCTION</title>
            <p>The fungi belonging to the eukaryotic kingdom possess heterotrophic nature [<xref ref-type="bibr" rid="r1">1</xref>]. They contain chitin in the cell wall, and their cell membranes are made up of sterols, glycerophospholipids, and sphingolipids [<xref ref-type="bibr" rid="r2">2</xref>]. Over the last 50 years, the number of patients with mycotic infections has been increasing as they are affected by many species of fungi like <italic>Aspergillus</italic>, <italic>Candida</italic>, <italic>Cryptococcus</italic>, and <italic>Pneumocystis</italic> [<xref ref-type="bibr" rid="r3">3</xref>]. Mycotic infections are unignorable causes of lethality in immune-deficient persons. The early detection of systemic mycotic infections in immune-compromised persons is still challenging due to the scarcity of sensitive diagnostic techniques [<xref ref-type="bibr" rid="r4">4</xref>]. In the current scenario, the only drug available in the market to cure these fungal infections at up to best is Amphotericin B (AmB) because it is resistant free and a safer candidate for severe fungal infections that occur during organ transplantations, acquired immune deficiency syndrome (AIDS), hematological malignancy, <italic>etc</italic>. Still, the huge problem is the availability of its formulation in the intravenous (IV) dosage form, which is uneasy for administration. So it&#x0027;s a big challenge for the researchers to formulate this drug in the oral dosage form.</p>
            <p>The applications of AmB in chemotherapy are limited because of high human toxicity and poor bioavailability [<xref ref-type="bibr" rid="r5">5</xref>]. AmB generally produces toxicity to the ergosterol-contain-ing fungal cell membrane, but it also interacts to some extent with the cholesterol-containing mammalian cell memb-</p>
            <p>rane, and as a result, of this, it produces toxicity to mammalian cells also [<xref ref-type="bibr" rid="r6">6</xref>]. AmB shows side effects including pyrexia, nausea, emesis, headache, low BP, allergic symptoms, and renal and hepatotoxicity [<xref ref-type="bibr" rid="r7">7</xref>]. Amphotericin-B is a BCS class IV drug because of poor solubility and permeability and comes under polyene macrolides. Amphotericin B was generated by Streptomyces nodosus in 1955 is the essential member of macrolides [<xref ref-type="bibr" rid="r8">8</xref>, <xref ref-type="bibr" rid="r9">9</xref>]. Its chemical aspects are still being explored because of its complex structure and a scarcity of appropriate synthetic techniques [<xref ref-type="bibr" rid="r8">8</xref>].</p>
            <p>Amphotericin B has applications in mycotic plant infections too. And they are also used as antiviral, antineoplastic [<xref ref-type="bibr" rid="r10">10</xref>-<xref ref-type="bibr" rid="r14">14</xref>], anti-leishmanial, against inflammation, against AIDS-related mycotic infections [<xref ref-type="bibr" rid="r15">15</xref>], against nosocomial fungal infections [<xref ref-type="bibr" rid="r16">16</xref>, <xref ref-type="bibr" rid="r17">17</xref>], against Alzheimer&#x0027;s, Creutzfeldt-Jakob, and human immune deficiency viral infections [<xref ref-type="bibr" rid="r18">18</xref>, <xref ref-type="bibr" rid="r19">19</xref>]. It is also employed against protozoal infections [<xref ref-type="bibr" rid="r20">20</xref>].</p>
            <sec id="sec1.1">
                <label>1.1</label>
                <title>Mechanism of Action of AmB</title>
                <p>The other antifungal drugs such as polyenes (damage mycotic membranes), azoles (suppress ergosterol biosynthesis), &#x0026; echinocandins (impede the formation of cell wall - glucan) are covered under three key categories of drugs with varied modes of action-still, all having limitations including toxicity, narrow spectrum, drug-drug interactions, and cost-ineffective. Amphotericin B binds to ergosterol, the leading constituent of the mycotic cell membrane [<xref ref-type="bibr" rid="r21">21</xref>]. Its function is revealed by an ion channel complex, which AmB and sterol compile into molecular assemblages. The renowned &#x201C;barrel-stave aggregation model,&#x201D; which consisted of around eight pairs of AmB/sterol, was introduced in the 1970s. AmB participates with sterols in phospholipid membranes to construct barrel-stave openings. The AmB molecules are aligned in a quasi-parallel orientation. Their polyhydroxy part points inward to set up the pore sheathing, and their lipophilic heptaene segment directs outward to link with the membrane interior (Fig. <bold><xref ref-type="fig" rid="f1">1</xref></bold>) [<xref ref-type="bibr" rid="r22">22</xref>-<xref ref-type="bibr" rid="r24">24</xref>].</p>
                <fig id="f1" position="float" fig-type="figure">
                    <label>Fig. (1)</label>
                    <caption>
                        <p>Different illustrations (<bold>1a</bold>, <bold>1b</bold>, and <bold>1c</bold>) for ion channel creation in the mycotic membrane. <xref ref-type="fig" rid="f1">Fig. (<bold><xref ref-type="fig" rid="f1">1a</xref></bold>)</xref> Reprinted (adapted) with permission from Matsumori, Nobuaki <italic>et al</italic>. {J. Am. Chem. Soc. 2005, 127, 30, 10667-10675}. Copyright {2005} American Chemical Society. Fig. (<xref ref-type="fig" rid="f1"><bold><xref ref-type="fig" rid="f1">1b</xref></bold></xref>) Reprinted (adapted) with permission from Palacios, Daniel S <italic>et al</italic>. {Proc Natl Acad Sci U S A. 2011 Apr 26; 108(17):6733-8}. Copyright {2011} National Academy of Sciences. Fig. (<xref ref-type="fig" rid="f1"><bold><xref ref-type="fig" rid="f1">1c</xref></bold></xref>) Reprinted (adapted) with permission from Szpilman, Alex M <italic>et al</italic>. {Angew Chem Int Ed Engl. 2008; 47(23):4339-42}. Copyright {2008} Wiley [<xref ref-type="bibr" rid="r13">13</xref>, <xref ref-type="bibr" rid="r23">23</xref>, <xref ref-type="bibr" rid="r24">24</xref>].</p>
                    </caption>
                    <graphic xlink:href="CTMC-22-19-1571-f1">
                    </graphic>
                </fig>
                <p>Yet, recent research has revealed that AmB&#x0027;s sterol-independent pores play a crucial role in its functions. The ion channel complex formation mechanism is vital for determining the bimolecular interactions between AmB-AmB and AmB-lipids [<xref ref-type="bibr" rid="r9">9</xref>]. The specifics of amphotericin B&#x0027;s mechanism of action remain a mystery after five decades of intensive study. Amphotericin B is believed to induce electrolyte and small molecule leakage from exposed cells. Yet, it must be confirmed if electrolyte discharge is the leading cause of Amphotericin-B induced cell death. The methods of mechanistic inquiry have been used in recent attempts [<xref ref-type="bibr" rid="r12">12</xref>, <xref ref-type="bibr" rid="r13">13</xref>, <xref ref-type="bibr" rid="r25">25</xref>]. AmB counteracts yeast in two ways: (i) ergosterol adhering dependent channel construction have needed for antifungal activity, or (ii) ergosterol adhering is a major mechanism of antifungal activity, with channel construction presenting as an auxiliary mechanism of action (Fig. <bold><xref ref-type="fig" rid="f2">2</xref></bold>) [<xref ref-type="bibr" rid="r26">26</xref>].</p>
                <p>The UV/CD spectroscopic methods and molecular dynamics calculations could not explore the details of the ion-permeable channel&#x0027;s molecular architecture. The molecular assemblage of AmB-sterol is assumed to reach dissociation/association equilibrium, arising in an exchange between the channel&#x0027;s conducting and non-conducting domains, rendering spectroscopic analysis of the active assemblage complicated. As an outcome, if dimers rather than monomers take part in this mechanism, the equilibrium should switch to the associated state, permitting NMR measurements to be recorded (Fig. <bold><xref ref-type="fig" rid="f3">3</xref></bold>) [<xref ref-type="bibr" rid="r9">9</xref>, <xref ref-type="bibr" rid="r27">27</xref>].</p>
                
                <p>Using solid-state NMR techniques, Oishi, T., and Murata, M. explored the molecular basis of AmB-ergosterol complexes in hydrated PC bilayers, a more physiologically pertinent system than freeze-dried or frozen membrane preparations [<xref ref-type="bibr" rid="r28">28</xref>].</p>
            </sec>
            <sec id="sec1.2">
                <label>1.2</label>
                <title>Chemistry Point of View of Amphotericin-B</title>
                <p>The Amphotericin-B possesses a large, highly complex structure (Fig. <bold><xref ref-type="fig" rid="f4">4</xref></bold>). Its scaffolding encompasses polyketide, which is hooked up to a mycosamine sugar. The hydrophobic polyene subunit is affixed to the hydrophilic polyol segment of the molecule. That&#x2019;s why it is classified as a polyene macrolide. It is embodied up of a 38-membered macrolactone nucleus glycosylated at C-19 hydroxyl position to the mycosamine [<xref ref-type="bibr" rid="r29">29</xref>]. The C-7 to C-10 polyol sites part of amphotericin B structure significantly influence the antifungal activity [<xref ref-type="bibr" rid="r30">30</xref>, <xref ref-type="bibr" rid="r31">31</xref>]. The (+)-charged amine is necessary for biological activity &#x0026; the polyene component is necessary for activity according to the pharmacophore of the AmB molecule (Fig. <bold><xref ref-type="fig" rid="f4">4</xref></bold>). The preference for ergosterol over cholesterol is reduced when the carboxyl group is negatively charged; nevertheless, N-aminoacylation improves selectivity. The absolute configuration of Amphotericin B was confirmed in 1970 using a single-crystal analysis of the N-iodoacetyl derivative of AmB [<xref ref-type="bibr" rid="r8">8</xref>, <xref ref-type="bibr" rid="r21">21</xref>].</p>
                <fig id="f2" position="float" fig-type="figure">
                    <label>Fig. (2)</label>
                    <caption>
                        <p>Representation of dual-type mechanisms for the antimycotic activity by AmB. Reprinted (adapted) with permission from Gray, Kaitlyn C <italic>et al.</italic> {Proc Natl Acad Sci U S A. 2012 Jan 17; 109 (7) 2234-2239}. Copyright {2012} National Academy of Sciences [<xref ref-type="bibr" rid="r26">26</xref>].</p>
                    </caption>
                    <graphic xlink:href="CTMC-22-19-1571-f2">
                    </graphic>
                </fig>
               
                <p>The C35-hydroxyl unit is speculated to be necessary for creating and stabilizing dimeric ion channels <italic>via</italic> hydrogen bonding [<xref ref-type="bibr" rid="r34">34</xref>]. AmB is a cyclic amphiphile composed of two long chains, a poly hydroxy, which is hydrophilic, and a hydrophobic polyene of seven double bond links conjugated with E geometry.</p>
                <p>Amphotericin B has the name Amphotericin B because of its amphoteric behavior [<xref ref-type="bibr" rid="r35">35</xref>]. AmB binds membrane-encapsulated ergosterol, the amplest sterol in yeast cells, in a form that necessitates the presence of the mycosamine appendage at C19, according to Gray, <italic>et al</italic>. Amphoterono- lide B (Fig. <bold><xref ref-type="fig" rid="f6">6</xref></bold>) is formed when the mycosamine appendage is removed from AmB, and then it is unable to bind ergosterol, create ion channels, and shows no antimycotic effect [<xref ref-type="bibr" rid="r26">26</xref>]. The mycosamine appendage is indispensable for ergosterol and cholesterol-binding, although the three functional groups&#x0027; respective roles at C2, C3, and C4 are anonymous [<xref ref-type="bibr" rid="r36">36</xref>].</p>
                <p>Resat <italic>et al</italic>. tell that the drug&#x0027;s selective toxicity is affected by amino sugar&#x0027;s relative orientation to the macrolide unit [<xref ref-type="bibr" rid="r12">12</xref>, <xref ref-type="bibr" rid="r13">13</xref>, <xref ref-type="bibr" rid="r32">32</xref>]. Fluorination is a reliable alternative for more fitting derivatives with diminished toxicity because of medical aftereffects [<xref ref-type="bibr" rid="r11">11</xref>]. A series of modified AmB derivatives, such as Amphotericin B methyl ester (AME) and numerous amide, N-alkyl, and N-acyl derivatives, have been developed to achieve more effective and less toxic therapeutics [<xref ref-type="bibr" rid="r37">37</xref>, <xref ref-type="bibr" rid="r38">38</xref>]. The polyamine conjugates of AmB possess the power to boost potency since the membrane is considered AmB&#x0027;s primary goal [<xref ref-type="bibr" rid="r16">16</xref>, <xref ref-type="bibr" rid="r17">17</xref>]. Burke <italic>et al</italic>. envisaged that the C2&#x0027; hydroxyl group on the mycosamine appendage is crucial for binding both sterols (ergosterol and cholesterol) using a commanding structural model [<xref ref-type="bibr" rid="r14">14</xref>]. The chemical alterations of AmB and the genetically engineered polyenes (at C16 carboxyl group or the amino group of mycosamine moiety) could emerge in unique derivatives with low toxicity and therapeutic efficacy [<xref ref-type="bibr" rid="r39">39</xref>]. The amphiphilic nature of AmB makes it weakly dissolved in most organic solvents and approximately insoluble in water under physiological conditions of pH values 6-7. It is administered through the intravenous (IV) route as a complex with sodium deoxycholate, which behaves as a dispersant, emerging in water-soluble micellar colloidal conglomerates with AmB [<xref ref-type="bibr" rid="r7">7</xref>]. The aggregates form of AmB is toxic to both mammalian and fungal cells, but the monomeric form is toxic only to fungal cells. The selective toxicity of AmB can be improved by the chemical modification on carboxyl and amine groups, respectively [<xref ref-type="bibr" rid="r40">40</xref>]. Day <italic>et al</italic>. inspected that in the presence of PLP (Vitamin), both AmB and nystatin are efficiently dissolved in water, reaping concentrations of greater than 100 mg/mL (the highest concentration evaluated) [<xref ref-type="bibr" rid="r41">41</xref>].</p>
               
                <p>Amphotericin B has the problem of toxicity, poor bioavailability, uncertain information about its mechanism of action, <italic>etc</italic>. So, there are separate chemical modification approaches for all the issues.</p>
            </sec>
        </sec>
        <sec id="sec2" sec-type="other1">
            <label>2</label>
            <title>The Chemical Modification Approaches of Amphotericin-B</title>
            <p>This section comprises <italic>five approaches</italic> emphasizing mechanism of action, biological activity, bioavailability, toxicity, and drug carriers.</p>
            <sec id="sec2.1">
                <label>2.1</label>
                <title>Chemical Modification Approach for the Investigation of the Mechanism of Action of Amphotericin-B</title>
                <p>The covalently conjoined dimers of AmB synthesized through cross-linking their carboxylic acid were described by Yamaji <italic>et al</italic>. A dimer (Fig. <bold><xref ref-type="fig" rid="f7">7</xref></bold>) with a 1, 6-hexanediamine linkage showed powerful hemolytic action (EC<sub>50</sub>, 0.25 M), while its N-acetyl derivative caused substantial K<sup>+</sup> ion leakage in phosphatidylcholine liposomes, despite the availability or unavailability of sterols, pointing that dimers might be used to decipher the structure of the Amphotericin B-induced ion channel assembly [<xref ref-type="bibr" rid="r9">9</xref>].</p>
                <p>An AmB dimer with a carboxylic acid connection was prepared using a simple reaction arrangement displayed in (Scheme <bold><xref ref-type="scheme" rid="s1">1</xref></bold>) [<xref ref-type="bibr" rid="r9">9</xref>].</p>
                <p>Matsumori <italic>et al</italic>. reported AmB dimers with the channel-forming ability for investigation of bimolecular recognition of AmB/sterol [<xref ref-type="bibr" rid="r27">27</xref>]. The stable fluorinated derivative of AmB carrying a fluorine atom in the macrolide backbone was reported by Matsumori <italic>et al</italic>. It was produced by employing a Selectfluor (electrophilic fluorination reagent). The claimed derivative had hemolytic, K<sup>+</sup> permeable, and antimycotic properties similar to AmB. Hence, predicted to be an appropriate means for NMR-based studies of the process of amphotericin B ion-channel creation. They also synthesized a conveniently accessible derivative 3 for NMR studies by employing the reductive amination to AmB along with a <sup>19</sup>F-labeled molecule (p-fluorobenzaldehyde) at the amino group (For scheme, Please refer to article) [<xref ref-type="bibr" rid="r11">11</xref>].</p>
                <p>Tsuchikawa <italic>et al</italic>. integrated chemical synthesis through cross-coupling reactions &#x0026; macrolactonization along with degeneration of a natural product to produce a fluorinated Amphotericin B (AmB) derivative, 28-<sup>19</sup>F-AmB methyl ester, tagged at the polyene part. The fluorinated derivative 3, which has an antimycotic activity identical to AmB, is envisioned to be a useful device for NMR-based studies of ion-channel creation mechanisms (For figure, Please refer to article) [<xref ref-type="bibr" rid="r37">37</xref>].</p>
                <p>Palacios <italic>et al</italic>. described an approach that removes synthetic groups affixed to the macrolide scaffold and assesses the functional outcomes. It recommends that oxidation at C(41) is not essential for potent antimycotic activity, and channel creation is also not required for the same, contrary to the existing channel hypothesis. They eventually came up with a diverse degradative method that allows for the synthetic reversal of one or both of the two post polyketide synthase modifications critical for AmB channel self-aggregation (Scheme <bold><xref ref-type="scheme" rid="s2">2</xref></bold>) [<xref ref-type="bibr" rid="r42">42</xref>].</p>
                
                <p>Szpilman <italic>et al</italic>. reported the synthesis of 35-deoxy AME (Fig. <bold><xref ref-type="fig" rid="f9">9</xref></bold>) utilizing a new approach for linking mycosamine to the aglycone. The (-OH) on C35 is important in the double-barrel construct&#x0027;s stability. This article addresses a method for completing the whole synthesis of AmB analogues, including glycosidation &#x0026; subsequent exploration processes. It describes its use in the manufacture of 35-deoxy AME in particular. It also presents data that experimentally affirms the significance of (-OH) at C35 in its antimycotic activity &#x0026; capacity to trigger electrolyte discharge in liposomes for the first time [<xref ref-type="bibr" rid="r24">24</xref>].</p>
                <p>For investigating the interaction among AmB &#x0026; ergosterol or cholesterol, Murata <italic>et al</italic>. synthesized <sup>13</sup>C &#x0026; <sup>19</sup>F-tagged covalent conjugates and used solid-state NMR studies. They calculated the gap between the fluorine atom and its most adjacent carbon in the heptaene part to be less than 8.6 by employing rotor-synchronous double-resonance studies such as rotational echo double resonance (REDOR) and RDX, showing that the B ring of ergosterol gets adjacent to the AmB polyene portion. In contrast to the popular notion in which ergosterol is injected into AmB molecules, a conformational inspection of the AmB-erg conjugate adopting NMR-derived constraints revealed that erg molecules besiege the AmB assemblage. Employing <sup>13</sup>C and <sup>19</sup>F-tagged AmBs in a dimyristoyl phosphatidylcholine (DMPC) membrane without sterols, the bimolecular inte- raction between AmB and AmB was investigated. The REDOR experiments identified 13C-19F dipolar interac- tions acquired from both head-to-head &#x0026; head-to-tail orientations and identified AmB interactions with the phos- pholipid&#x0027;s acyl chains. They synthesized labeled compounds and chemically conjugated them to stabilize the AmB-sterol interaction (For scheme, please refer to article). AmB was electrophilically labeled with a fluorine atom at C14 to produce fluorine-labeled AmB (For scheme, please refer to article). By nourishing the microbes 3-<sup>13</sup>C-propionic acid, <sup>13</sup>C was integrated into C39, C40, &#x0026; C41, resulting in <sup>13</sup>C-labeled AmB at both terminal locations (For scheme, please refer to article). As given in the schematic, the chemical synthesis of the polyene/tail region of AmB was brought out further to attain <sup>13</sup>C and <sup>19</sup>F-tagged AmB at the polyene portion (For scheme, please refer to article) [<xref ref-type="bibr" rid="r22">22</xref>].</p>
                <p>Szpilman <italic>et al</italic>. reported (a) The molecular editing employed for the interpretation of the AmB function and (b) A standard approach for the synthesis of AmB and its prepared analogues, which depends on an economic gram-scale synthesis of distinct amphotericin B subunits, (c) A innovative approach for conjoining the mycosamine to the aglycone, (d) Inspection of the antimycotic activity &#x0026; efflux causing capability of AmB analogue contributed new keys to the function of the 35-hydroxy group. This study described the synthetic production of 35-deoxy AME in detail and biophysical experiments that indicated the influence of the C35-hydroxy group on bioactivity. Alter- native pathways to the C1-C13 &#x0026; C33-C37 portions were also revealed (For schemes, please refer to the article) [<xref ref-type="bibr" rid="r34">34</xref>].</p>
                <p>Palacios <italic>et al</italic>. reported a dominant cluster of functional groups lacking probes that exposed ion channel anatomy and Amphotericin B antifungal activity. In contradiction to the two dominant models, polar interactions between mycosamine &#x0026; carboxylic acid auxiliaries on adjacent Amphotericin B molecules are not necessary for ion channel development or binding to phospholipid bilayers. The mycosamine sugar is also essential for developing a direct binding affinity among amphotericin B &#x0026; ergosterol, which supports a hitherto unproven third theory. The same may be said of cholesterol. Ion channel and antifungal actions are likewise fully eliminated when this appendage is synthetically deleted. It means that both channel creation and yeast cell death require a mycosamine arbitrated straight binding relationship between amphotericin B &#x0026; ergosterol [<xref ref-type="bibr" rid="r23">23</xref>].</p>
                <p>Wilcock <italic>et al</italic>. reported changing the electronic nature of the reagents to tune site selectivity. They were able to modify one of the numerous hydroxyl groups connected to the ion channel creating the natural substance amphotericin B with these breakthroughs. As a result, electronic tuning of reagents is a viable technique for identifying and optimizing site-specific functionalization reactions [<xref ref-type="bibr" rid="r36">36</xref>].</p>
                <p>AmB&#x0027;s high fungicidal activity is not dependent on channel formation, according to Gray <italic>et al</italic>. This is confirmed by preparing a functional group lacking a derivative of this natural product <italic>via</italic> iterative cross-coupling. AmB, on the other hand, destroyed yeast by sticking to ergosterol, a lipid essential for abounding facets of yeast cell function [<xref ref-type="bibr" rid="r26">26</xref>].</p>
                <p>Umegawa <italic>et al</italic>. employed <sup>13</sup>C{<sup>19</sup>F} <sup>19</sup>F-REDOR investigations using C14-tagged AmB &#x0026; biosynthetically <sup>13</sup>C-tagged ergosterol to decode the style of molecular interactions between AmB &#x0026; ergosterol in aquated phos- pholipid bilayers, implying that each &#x201C;head-to-head&#x201D; &#x0026; &#x201C;head-to-tail&#x201D; AmB orientations ensue for ergosterol [<xref ref-type="bibr" rid="r28">28</xref>].</p>
                <p>The international patent WO 2014/059436 Al reported the site-selective functionalization of Amphotericin B was achieved merely by altering the reagents&#x0027; electronic nature. One of many hydroxyl groups added to the ion channel-creating natural product amphotericin B was modified in various ways. The method comprises the steps of selecting, based on its electron richness, a functionalizing reagent for reaction with at least one potential site for functionalization of a substrate molecule having a plurality of potential sites for functionalization; and reacting the functionalizing reagent with at least one of potential sites for functiona- lization in a reaction represented by S+R(D)&#x2192;S(D) wherein S represents the substrate molecule having a plurality of potential sites for functionalization; R(D) represents the functionalizing reagent comprising a functional group [<xref ref-type="bibr" rid="r43">43</xref>].</p>
                <p>&#x201C;The alteration of functional groups that modify the conductance of the AmB ion channel was described by Davis <italic>et al</italic>. The C3-OH group was synthesized &#x0026; the resultant compound, C3deoxyAmB (C3deOAmB), was analyzed utilizing multidimensional NMR measure- ments &#x0026; single ion channel electrophysiological recordings to test the idea. Although C3deOAmB channels have the unchanged macrocycle structure as AmB &#x0026; can create transmembrane ion channels, their conductance is three times lower than AmB channels. As a result, the C3-hydroxyl group performs a crucial character in AmB ion channel conductance, &#x0026; synthetic changes at this point may enable more channel function tailoring&#x201D; [<xref ref-type="bibr" rid="r44">44</xref>, <xref ref-type="bibr" rid="r45">45</xref>].</p>
                <p>&#x201C;To deeply learn the mechanism of antimycotic activity, Yamamoto <italic>et al</italic>. used ssNMR to study the molecular orientation of AmB. The NMR isotope-labeled AME, d3-AME, and its fluorinated or <sup>13</sup>C-labeled derivatives were synthesized. All AmB derivatives had identical membrane-disrupting capabilities and UV spectra in phospholipid liposomes, implying that their molecular assemblages in membranes are quite comparable to those of AmB. Accor- ding to solid-state 2H NMR observations of d3-AME in a hydrated membrane, the AME molecule&#x0027;s mobility depends on concentration and temperature. AME got sufficiently mobilized to witness motional averaging of quadrupole coupling at a 1:5:45 AME:Erg:dimyristoyl-phosphatidyl- choline ratio. They observed that the molecular axis of AME is mainly parallel to the typical lipid bilayer, counting on the average rotational effect of <sup>19</sup>F chemical shift anisotropy, 2H quadrupolar splitting, and <sup>13</sup>C-<sup>19</sup>F dipolar coupling of 14-F-AMEs.This finding backs with the barrel-stave model of AmB molecule assembly in membranes (For schemes, please refer to article)&#x201D; [<xref ref-type="bibr" rid="r46">46</xref>].</p>
                <p>The summary of the above approach through the author&#x2019;s contribution is given in Table <bold><xref ref-type="table" rid="t1">1</xref></bold> below.</p>
            </sec>
            <sec id="sec2.2">
                <label>2.2</label>
                <title>Chemical Modification Approach for the Investigation of Biological Activity Produced by Amphotericin-B</title>
                <p>Schaffner and co-patentor Mechlinski patented derivatives of amphoteric polyene macrolide antibiotics, comprising (a) the (-CH<sub>3</sub>), (-C<sub>2</sub>H<sub>5</sub>), or (-C<sub>3</sub>H<sub>7</sub>), ester created through the esterification of the (-COOH), &#x0026; (b) salts of these esters formed with the (-NH<sub>2</sub>) group for the study of biological activity of Amphotericin B. The derivatives of (a) &#x0026; (b) had effective antifungal activity compared to the parent antibiotics. The reagents like CH<sub>2</sub>N<sub>2</sub>, C<sub>2</sub>H<sub>4</sub>N<sub>2</sub> &#x0026; C<sub>3</sub>H<sub>6</sub>N<sub>2</sub> are more efficacious &#x0026; astonishingly choosy for polyene antibiotics, specifically preventing unwanted reactions for esterification. The acid salts (b) of Schaffner <italic>et al</italic>., produced by suitable acids, <italic>e.g</italic>., hydrochlorides, showed great aqueous dissolution that is usually not shown by parent drug &#x0026; also have particular benefit in retaining the strong activity [<xref ref-type="bibr" rid="r47">47</xref>].</p>
                <table-wrap id="t1" position="float">
                    <label>Table 1</label>
                    <caption>
                        <title>The summary of the chemical modification approach of investigating the mechanism of action of Amphotericin-B.</title>
                    </caption>
                    <table frame="border" rules="all" width="100%">
                        <thead>
                            <tr>
                                <th valign="middle" align="center" scope="col">
                                    <bold>S. No.</bold>
                                </th>
                                <th valign="middle" align="center" scope="col">
                                    <bold>Authors</bold>
                                </th>
                                <th valign="middle" align="center" scope="col">
                                    <bold>Contribution</bold>
                                </th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td valign="middle" align="center" scope="row">1</td>
                                <td valign="middle" align="center">Yamaji <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;The dimers may perform as a means for analyzing the structure of the ion channel assemblage created by Amphotericin B&#x201D; [<xref ref-type="bibr" rid="r9">9</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">2</td>
                                <td valign="middle" align="center">Matsumori <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;AmB dimers with the channel-forming ability for investigating bimolecular recognition of AmB/sterol&#x201D; [<xref ref-type="bibr" rid="r27">27</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">3</td>
                                <td valign="middle" align="center">Matsumori <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Fluorination-based tool for NMR-based investigations of the mechanism of ion-channel creation by Amphotericin B&#x201D; [<xref ref-type="bibr" rid="r11">11</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">4</td>
                                <td valign="middle" align="center">Tsuchikawa <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Fluorinated Amphotericin B (AmB) derivative, 28-<sup>19</sup>F-AmB methyl ester, tagged at the polyene moiety, was hoped to be a powerful tool for NMR-based investigation of the mechanism of ion-channel formation&#x201D; [<xref ref-type="bibr" rid="r37">37</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">5</td>
                                <td valign="middle" align="center">Palacios <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;An alternative strategy involves synthetically eliminating chemical groups attached to the macrolide framework and detecting the functional consequences&#x201D; [<xref ref-type="bibr" rid="r42">42</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">6</td>
                                <td valign="middle" align="center">Kasai <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Synthesized <sup>13</sup>C- &#x0026; <sup>19</sup>F-tagged covalent conjugates as disclosed formerly to check out the interaction between AmB &#x0026; ergosterol (Erg) or cholesterol (Cho)&#x201D; [<xref ref-type="bibr" rid="r38">38</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">7</td>
                                <td valign="middle" align="center">Szpilman <italic>et al.</italic></td>
                                <td valign="middle" align="center">&#x201C;Reported the synthesis of 35-deoxy amphotericin B methyl ester. In stabilizing the double-barrel construct, the hydroxy group on C35 is considered an essential role&#x201D; [<xref ref-type="bibr" rid="r24">24</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">8</td>
                                <td valign="middle" align="center">Murata <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Prepared the <sup>13</sup>C and <sup>19</sup>F-tagged covalent conjugates to check the interaction between AmB &#x0026; ergosterol or cholesterol and subjected them to solid-state NMR analyses&#x201D; [<xref ref-type="bibr" rid="r22">22</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">9</td>
                                <td valign="middle" align="center">Szpilman <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Reported the application of molecular editing to elucidate the mechanism of action of AmB&#x201D; [<xref ref-type="bibr" rid="r34">34</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">10</td>
                                <td valign="middle" align="center">Palacios <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Reported a strong set of functional groups lacking probes that unveiled anatomy of the ion channel &#x0026; antimycotic activities of amphotericin B&#x201D; [<xref ref-type="bibr" rid="r23">23</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">11</td>
                                <td valign="middle" align="center">Wilcock <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Reported the tuning of site-selectivity by altering the electronic nature of the reagents [<xref ref-type="bibr" rid="r36">36</xref>]&#x201D;.</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">12</td>
                                <td valign="middle" align="center">Gray <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;They discovered that channel formation is not required for the potent fungicidal activity of AmB&#x201D; [<xref ref-type="bibr" rid="r26">26</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">13</td>
                                <td valign="middle" align="center">Umegawa <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;They elucidated the way of molecular interactions between AmB &#x0026; ergosterol in hydrated phospholipid bilayers&#x201D; [<xref ref-type="bibr" rid="r28">28</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">14</td>
                                <td valign="middle" align="center">Burke, <italic>et al</italic>. (WO 2014/059436 Al)</td>
                                <td valign="middle" align="center">&#x201C;They achieved a range of modifications to one of the many hydroxyl groups attached to the ion channel-forming natural product Amphotericin B&#x201D; [<xref ref-type="bibr" rid="r43">43</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">15</td>
                                <td valign="middle" align="center">Davis <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Reported the modification of functional group that alters conductance of the AmB ion channel&#x201D; [<xref ref-type="bibr" rid="r44">44</xref>, <xref ref-type="bibr" rid="r45">45</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">16</td>
                                <td valign="middle" align="center">Yamamoto <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Investigated the molecular orientation of AmB employing solid-state nuclear magnetic resonance (NMR) to understand the mechanism of antimycotic activity more&#x201D; [<xref ref-type="bibr" rid="r46">46</xref>].</td>
                            </tr>
                        </tbody>
                    </table>
                </table-wrap>
                <p>To more appropriately determine the affiliation among the amino-sugar orientation and pharmacological action, Matsumori and his co-workers developed rigid compounds having bridged (-NH<sub>2</sub>) &#x0026; (-COOH) groups along with varied alkyl chains. K<sup>+</sup> influx assays throughout the lipid bilayer membrane displayed that ergosterol selectivity varied significantly amid compounds, indicating that some lost activity while others had a stronger ergosterol preference than AmB. Because of the short bridge, the amino-sugar moiety of one derivative comes close to C41, whereas those of others point outward, according to the Monte Carlo conformational study of selected derivatives pertaining to NOE determined distances. These findings explain AmB-sterol interactions, in which H-bonding between AmB&#x0027;s 2&#x0027;-OH and ergosterol&#x0027;s 3&#x0027;-OH plays a key role (For schemes, please refer to article) [<xref ref-type="bibr" rid="r13">13</xref>].</p>
                <p>Through a twofold reductive alkylation of the mycosamine, Paquet and his co-worker Carreira generated novel derivatives of Amphotericin B (AmB). These AmB derivatives outperformed the wild-type Saccharomyces cerevisiae strain in antifungal activity, exclusively anti to AmB resistant <italic>Candida albicans</italic> strain. Furthermore, these derivatives had considerably lower hemotoxicity than AmB, making them suitable therapeutic candidates. And they identified that alkylation of the mycosamine moiety of AmB with 2-aminopropylene (Fig. <bold><xref ref-type="fig" rid="f10">10</xref></bold>) groups contributes to congeners with considerably augmented antimycotic activity also to an AmB-resistant strain. This noted increment in bio-activity allowed speedy access to C-16 carboxylate compounds with diminished hemotoxicity and retained high efficacy. Mini- mal inhibitory concentration (MIC) against <italic>S. cerevisiae</italic> for AmB was 0.30 &#x00B5;M, and for bis (aminopropylene) derivative was 0.020 &#x00B5;M [<xref ref-type="bibr" rid="r48">48</xref>].</p>
               
                <p>Matsumori and his co-worker Sawada and Michio Murata, to decipher more about the active conformation of AmB, developed a fresh intramolecular-bridged derivative, in which a linker attached to a hydrophilic glycine part. The derivative&#x0027;s ion-channel action is nearly identical to that of the AmB &#x0026; the previously reported derivative. One deriva- tive&#x0027;s antifungal activity improves surprisingly compared to the other, probably because the linker&#x0027;s increased hydro- philicity improves penetrability through the fungal cell wall. The ssNMR method was applied to confirm the active framework of AmB. (For scheme, please refer to article) [<xref ref-type="bibr" rid="r12">12</xref>].</p>
                <p>Zumbuehl <italic>et al</italic>. proposed &#x201C;a novel linker technique relied on 2-fold reductive amination of a dialdehyde to the amine of the AmB, also a comparison of the biological activity of conjugates to AmB. They also disclosed synthesizing the extra conjugates employing a piperazine linker &#x0026; a related conjugation strategy involving a 4-carboxy- piperidinyl linker.&#x201D; (For scheme, please refer to article) [<xref ref-type="bibr" rid="r49">49</xref>].</p>
                <p>Paquet <italic>et al</italic>. mentioned novel cationic AmB deri- vatives obtained by modifying amine &#x0026; carboxyl moiety of AmB, emphasizing polyamine derivatives with two 3-aminopropyl chains on the mycosamine. For the evaluation of bio-activity, the EH<sub>50</sub> values were used. The net charge on the AmB favored the monomeric form by hindering self-association with reduced toxicity. The cationic AmB derivative increases essential H-bond ability following the proposed ion channel model. The presence of polar functional groups may give rise to the formation of water-soluble salts. The polyamines efficiently interact with negatively charged phospholipids in the biological memb- rane (For all schemes, please refer to the article) [<xref ref-type="bibr" rid="r16">16</xref>].</p>
                <p>The international patent WO 2015/164289 Al <italic>et al</italic>. reported the constitutions &#x0026; approaches for treating mycotic infections, including compounds containing a chemotaxis receptor-ligand moiety and a polyene antifungal agent moiety. Specifically, the compounds containing a polyene antifungal agent and a formyl peptide receptor ligand can be used to treat fungal infections caused by a fungus of the genus Aspergillus or Candida [<xref ref-type="bibr" rid="r50">50</xref>].</p>
                <p>The international patent WO 2015/168568 Al disclosed the derivatives mainly [C16 ureas, amides, &#x0026; carbamates (Formula I)], [C3&#x0027;-substituted C16 ureas, amides, &#x0026; carbamates (Formula II)], [C16 acyls (Formula III)], [C2&#x0027;epi-C16 ureas, amides, &#x0026; carbamates (Formula IV)], and [C16 oxazolidinone derivatives (Formula V)] of AmB with better therapeutic index compared to parent AmB [<xref ref-type="bibr" rid="r51">51</xref>].</p>
                <p>
                
                
                 xlink:href="CTMC-22-19-1571-i1"/></p>
                <p>The international patent WO 2016/014779 Al reported the antifungal C2&#x0027;-epi-polyene macrolides with surprisingly improved therapeutic index compared to corresponding mycosamine comprising polyene macrolides. It also provided the methods for making the antifungal C2&#x0027;-epi-polyene macrolides, pharmaceutical compositions comprising the antifungal C2&#x0027;-epi-polyene macrolides, and approaches to impeding the proliferation of yeast or yeast fungus with the antifungal C2&#x0027;-epi-polyene macrolides, and methods of treating a fungal infection with the antifungal C2&#x0027;-epipolyene macrolides [<xref ref-type="bibr" rid="r52">52</xref>].</p>
                <p>Chugunova <italic>et al</italic>. reported the hybrid compounds 5-7 (yield of 54- 68%) prepared by reactions of benzofuroxans 2-4 with Amphotericin-B (1a) &#x0026; nystatin (1b) for improvement in biological activity [For scheme, please refer to the article] [<xref ref-type="bibr" rid="r53">53</xref>].</p>
                <p>Jose David Flores-Romero <italic>et al</italic>. reported the multigram scale synthesis, isolation, and purity evaluation by HPLC &#x0026; NMR evaluation of the A21 derivative. This novel AmB amide derivative on pre-clinical trials showed a similar antifungal effect &#x0026; enhanced margin of safety compared to AmB. (For scheme, please refer to article) [<xref ref-type="bibr" rid="r54">54</xref>].</p>
                <p>The international patent WO 2017/100171 Al reported the Formula (I) and (II) compounds and pharmaceutical preparations of these compounds, salts or combinations, and their method of preparation. These compounds, salts, &#x0026; compositions helped inhibit fungal growth (For scheme, Please refer to article) [<xref ref-type="bibr" rid="r55">55</xref>].</p>
                <p><inline-graphic xlink:href="CTMC-22-19-1571-i2"/></p>
                <p>The international patent WO 2018/106571 Al reported the compounds of the Formulae (I) and (II), as well as methods for using them to make compounds of the Formula (IIIa) and/or (IIIb), and/or other compounds of the Formulae (I) and (II). Such compounds, salts, and compositions are useful for inhibiting fungal growth (For all formulae, please refer to patent) [<xref ref-type="bibr" rid="r56">56</xref>].</p>
                <p><inline-graphic xlink:href="CTMC-22-19-1571-i3"/></p>
                <p>The international patent WO 2014/165676 Al reported the Amphotericin-B (AmB) derivative with better therapeutic effect than AmB, pharmaceutical preparations containing it, methods of its preparation &#x0026; its use in preventing the proliferation of yeast or fungus. The Amphotericin-B derivative, C2&#x0027;deOAmB (For figure, Please refer to article), doesn&#x2019;t have the hydroxyl group at the 2&#x0027; position on mycosamine, so it differs from the parent compound. This modified derivative had retained the capability to bind ergosterol and stop yeast growth with reduced toxicity to human cells by not binding to cholesterol [<xref ref-type="bibr" rid="r14">14</xref>].</p>
                <p>The summary of the above approach through the author&#x2019;s contribution is given in Table <bold><xref ref-type="table" rid="t2">2</xref></bold> below.</p>
            </sec>
            <sec id="sec2.3">
                <label>2.3</label>
                <title>The Chemical Modification Approach of Amphotericin B for Bioavailability Improvement</title>
                <p>Greatly water dissolving N-alkylguanidine/N-acylurea bis-adduct of AmB was obtained by reaction of Amphotericin B in DMF with bis(dimethylamino propyl)carbodiimide as disclosed by Adediran <italic>et al</italic>. Its water absorption spectra had shown good monomerization &#x0026; antimycotic activity against <italic>Candida albicans</italic> with reference AmB was comparable. It was less pro-inflammatory because of less effective in engaging TLR4. They also attempted coupling spermine to carboxylic acid by employing carbodiimide chemistry. That adduct had equipotent antifungal action against <italic>Candida albicans</italic>, and it also triggered toll-like receptor-2 (TLR2) and TLR4-driven NF-&#x03BA;B responses in reporter gene assays identical to AmB molecule (For schemes, please refer to the article) [<xref ref-type="bibr" rid="r33">33</xref>].</p>
                <p>Nicolaou <italic>et al</italic>. reported the series of protected derivatives of AmB. They have shown that one compound is converted to fragments by degradation through ozonolysis. They also performed the degradation of compounds to heptanones using an exclusive oxidative deglycosylation technique depending on radical bromination. The heptanones were then stereospecifically reduced to amphoteronolide B derivatives using sodium borohydride. Using Nakanishi&#x0027;s CD technique, they validated the R form of the C-19 (-OH) group. They accessed the aglycon of AmB, amphoteronolide B through desilylation &#x0026; (-CH<sub>3</sub>) ester hydrolysis. They got the diacetonide methyl ester derivative as a mixture of two isomers in 66% overall yield by treating acetamide methyl ester derivative with MeOH: Me<sub>2</sub>C(OMe)<sub>2</sub> (3:1) under acid catalysis (CSA) at 25&#x00B0;C from Amphotericin B. The excellent solubility characteristics exhibited by this derivative and compounds developed from it in popular organic solvents, and it acted chromatographically &#x0026; spectroscopically generally [<xref ref-type="bibr" rid="r57">57</xref>].</p>
                <table-wrap id="t2" position="float">
                    <label>Table 2</label>
                    <caption>
                        <title>The summary of the chemical modification approach for investigating biological activity produced by Amphotericin B.</title>
                    </caption>
                    <table frame="border" rules="all" width="100%">
                        <thead>
                            <tr>
                                <th valign="middle" align="center" scope="col">
                                    <bold>S. No.</bold>
                                </th>
                                <th valign="middle" align="center" scope="col">
                                    <bold>Authors</bold>
                                </th>
                                <th valign="middle" align="center" scope="col">
                                    <bold>Contribution</bold>
                                </th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td valign="middle" align="center" scope="row">1</td>
                                <td valign="middle" align="center">Carl P. Schaffner and <break/>Witold Mechlinski</td>
                                <td valign="middle" align="center">&#x201C;Patented the (a) (-CH<sub>3</sub>), (-C<sub>2</sub>H<sub>5</sub>), or (-C<sub>3</sub>H<sub>7</sub>), ester created through the esterification of the (-COOH), &#x0026; (b) salts of these esters formed with the (-NH<sub>2</sub>) group for the study of biological activity of Amphotericin B. These esters showed good water solubility and biological activity&#x201D; [<xref ref-type="bibr" rid="r47">47</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">2</td>
                                <td valign="middle" align="center">Nobuaki Matsumori <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;To more appropriately determine the affiliation among the amino-sugar orientation and pharmacological action, they developed rigid compounds having bridged (-NH<sub>2</sub>) &#x0026; (-COOH) groups along with varied alkyl chains&#x201D; [<xref ref-type="bibr" rid="r13">13</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">3</td>
                                <td valign="middle" align="center">Valerie Paquet and his <break/>co-worker Erick M. Carreira</td>
                                <td valign="middle" align="center">&#x201C;Through a twofold reductive alkylation of the mycosamine, they generated novel Amphotericin B (AmB) derivatives. These AmB derivatives outperformed the wild-type Saccharomyces cerevisiae strain in antimycotic activity, exclusively anti to AmB resistant Candida albicans strain&#x201D; [<xref ref-type="bibr" rid="r48">48</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">4</td>
                                <td valign="middle" align="center">Nobuaki Matsumori <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;To decipher more about the active conformation of AmB, they developed a fresh intramolecular bridged derivative, in which linker attached to a hydrophilic glycine part&#x201D; [<xref ref-type="bibr" rid="r12">12</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">5</td>
                                <td valign="middle" align="center">Andreas Zumbuehl <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;A novel linker technique relied on 2-fold reductive amination of a dialdehyde to the amine of the AmB, also a comparison of the biological activity of a set of conjugates to AmB&#x201D; [<xref ref-type="bibr" rid="r49">49</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">6</td>
                                <td valign="middle" align="center">Valerie Paquet <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;They mentioned novel cationic AmB derivatives obtained by modifying amine &#x0026; carboxyl moiety of AmB, emphasizing polyamine derivatives with two 3-aminopropyl chains on the mycosamine. For the evaluation of bio-activity, the EH<sub>50</sub> values were used&#x201D; [<xref ref-type="bibr" rid="r16">16</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">7</td>
                                <td valign="middle" align="center">Judice, James, Kevin <italic>et al</italic>.<break/>(WO 2015/164289 Al)</td>
                                <td valign="middle" align="center">&#x201C;Reported the constitutions &#x0026; approaches for treating mycotic infections, including compounds containing a chemotaxis receptor-ligand moiety and a polyene antifungal agent moiety&#x201D; [<xref ref-type="bibr" rid="r50">50</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">8</td>
                                <td valign="middle" align="center">Burke Martin D. <italic>et al</italic>. <break/>(WO 2015/168568 Al)</td>
                                <td valign="middle" align="center">&#x201C;Disclosed the derivatives mainly [C16 ureas, amides, &#x0026; carbamates (Formula I)], [C3&#x0027;-substituted C16 ureas, amides, &#x0026; carbamates (Formula II)], [C16 acyls (Formula III)], [C2&#x0027;epi-C16 ureas, amides, &#x0026; carbamates (Formula IV)], and [C16 oxazolidinone derivatives (Formula V)] of AmB with better therapeutic index compared to parent AmB&#x201D; [<xref ref-type="bibr" rid="r51">51</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">9</td>
                                <td valign="middle" align="center">Burke <italic>et al</italic>. <break/>(WO 2016/014779 Al)</td>
                                <td valign="middle" align="center">&#x201C;The antifungal C2&#x0027;-epi-polyene macrolides with surprisingly improved therapeutic index compared to corresponding mycosamine comprising polyene macrolides&#x201D; [<xref ref-type="bibr" rid="r52">52</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">10</td>
                                <td valign="middle" align="center">E. A. Chugunova <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;They reported the hybrid compounds 5-7 (yield of 54- 68%) prepared by reactions of benzofuroxans 2-4 with amphotericin B (1a) &#x0026; nystatin (1b) for improvement in biological activity&#x201D;[ <xref ref-type="bibr" rid="r53">53</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">11</td>
                                <td valign="middle" align="center">Jose David Flores-Romero <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Reported the multigram scale synthesis, isolation, purity evaluation by HPLC, &#x0026; NMR evaluation of A21 derivative. This novel AmB amide derivative on pre-clinical trials showed a similar antifungal effect &#x0026; enhanced margin of safety compared to AmB&#x201D; [<xref ref-type="bibr" rid="r54">54</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">12</td>
                                <td valign="middle" align="center">Pinchman, <italic>et al</italic>. <break/>(WO 2017/100171 Al)</td>
                                <td valign="middle" align="center">&#x201C;Reported the compounds of the Formula (I) and (II) for inhibiting fungal growth&#x201D; [<xref ref-type="bibr" rid="r55">55</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">13</td>
                                <td valign="middle" align="center">Bunker, Kevin, Duane, and his co-authors Pinchman and Joseph Robert (WO 2018/106571 Al)</td>
                                <td valign="middle" align="center">&#x201C;Reported the compounds of the Formulae (I) and (II) for inhibiting fungal growth&#x201D; [<xref ref-type="bibr" rid="r56">56</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">14</td>
                                <td valign="middle" align="center">Burke, Martin, D., and his co-worker Wilcock, Brandon, Endo, Matthew, M.; Uno, Brice, E. (WO 2014/165676 Al)</td>
                                <td valign="middle" align="center">&#x201C;The amphotericin B (AmB) derivative was reported with better therapeutic effect than AmB&#x201D; [<xref ref-type="bibr" rid="r14">14</xref>].</td>
                            </tr>
                        </tbody>
                    </table>
                </table-wrap>
                <p>The strategies for synthesizing immense purity alkyl esters of polyene macrolide antibiotics have been patented by Mohan and his co-worker Somerville; the reaction media, polyene antibiotics react with an aldehyde to constitute a soluble Schiff base. The alkyl ester of the polyene macrolide antibiotic is then generated as a Schiff base derivative by alkylating the solution in the presence of a hindered tertiary amine as an acid acceptor. The Schiff base derivative is converted to the desired alkyl ester of the polyene macrolide antibiotic by contacting it with water, which is recovered from the reaction media. This invention concerns new Schiff base intermediates of amphoteric polyene macrolides, their transformation to alkyl esters, &#x0026; their use in synthesizing polyene macrolide esters &#x0026; water dissolving salts correspondingly [<xref ref-type="bibr" rid="r10">10</xref>].</p>
                <p>The two novel categories of amide derivatives of polyene macrolide with greater water solubility than native AmB &#x0026; Amphotericin-B methyl ester (AME) beneficial towards mycotic infections had been patented by Chang <italic>et al</italic>. having international patent number WO 01/91758 Al. [<xref ref-type="bibr" rid="r32">32</xref>] One class affords polyene macrolide amide derivatives as per the structural formula 1 and the second class affords polyene macrolide amide derivatives as per the structural formula 2. The subsequent exploration of the formulae (I) and (II) in which N-R1-C(O) is a polyene macrolide backbone derived from AmB to structures (Ia) and (IIa), respectively (For detailed information, please refer to patent) [<xref ref-type="bibr" rid="r32">32</xref>].</p>
                <p><inline-graphic xlink:href="CTMC-22-19-1571-i4"/></p>
                <p>Elgart <italic>et al</italic>. announced the alteration in the distri- bution of AmB when conjugated to AG in correspondence to the molecular weight of the conjugated polysaccharide. When conjugated to H-Mw AG, poorly water dissolving AmB with comprehensive disposition and high clearance converted into greatly dissolving AmB with small Vd and deficient clearance. This is due to the high molecular weight of the conjugate limiting its permeability and resulting in a greater concentration of AmB &#x0026; <italic>vice versa</italic> with low molecular weight conjugate. Hence conjugation of AmB with AG yielded a novel entity with altered pharmacokinetic characteristics [<xref ref-type="bibr" rid="r58">58</xref>]. Day <italic>et al</italic>. disclosed the application of pyridoxal phosphate (PLP) for achieving excellent solubilization of AmB [<xref ref-type="bibr" rid="r41">41</xref>].</p>
                <p>Abeer <italic>et al</italic>. found that Amphotericin-B can form non-covalent complexes with Poly(&#x03B1;-glutamic acid). Com- pared to the parent molecule, this combination exhibited stability and lower toxicity in human RBC &#x0026; KB cells. At concentrations of 50 and 200 g/mL of AmB, the cell viability was stable. This combination forms durable water dissolving &#x0026; non-covalent complex with AmB to treat Leishmaniasis [<xref ref-type="bibr" rid="r59">59</xref>].</p>
                <p>The international patent WO 2013/186384 Al reported the semisynthetic N-substituted derivatives of AmB and their aqueous salts as well as pharmaceutical preparations and also disclosed the products for plant &#x0026; building treatments constituting these derivatives and their application as antimycotic agents according to the following formula I (For detailed information, please refer to the patent) [<xref ref-type="bibr" rid="r60">60</xref>].</p>
                <p><inline-graphic xlink:href="CTMC-22-19-1571-i5"/></p>
                <p>V. V. Belakhov <italic>et al</italic>. disclosed the chemical modi- fication of Amphotericin B with dialkyl(diaryl)-phosphites through the Atherton-Todd reaction and also studied toxicity and anti-mycotic activity of the synthesized derivatives. The introduction of the phosphoryl group significantly increased the solubility of prepared derivatives. The dialkyl-(diaryl) amidophosphonate derivatives I-V were prepared by reacting AmB &#x0026; dialkyl(diaryl)-phosphites (Please refer to the article for the scheme) [<xref ref-type="bibr" rid="r19">19</xref>].</p>
                <p>Antillon <italic>et al</italic>. reported the novel L-histidine methyl ester of Amphotericin B (A21) derivative with improved selectivity. It reduced dimerization in solution, and pre-clinical studies suggest it is similarly effective as the AmB. It has a higher water solubility than AmB because it is solubilized at 50 mMol while AmB at &#x03BC;Mol range (For the synthesis of A21 derivative, Please refer to article) [<xref ref-type="bibr" rid="r20">20</xref>].</p>
                <p>The synthesis of a novel series of AmB conjugates with benzoxaboroles was reported by Tevyashova <italic>et al</italic>. The antifungal activity of conjugates was identical to that of native AmB when tested adopting the broth microdilution method on yeast (<italic>Candida albicans</italic> and Cryptococcus humicolus) &#x0026; filamentous fungus (<italic>Aspergillus niger</italic> and <italic>Fusarium oxysporum</italic>). The di-modified conjugate 2-(N, N dimethylamino)ethylamide of 3-N-[<xref ref-type="bibr" rid="r3">3</xref>-(1-hydroxy-1,3-dihydrobenzo [c][<xref ref-type="bibr" rid="r1">1</xref>,<xref ref-type="bibr" rid="r2">2</xref>]oxaborol-7-yl)propanoyl] AmB confirmed the optimum combination of antimycotic efficacy, toxicity, and hemolysis. To enhance the solubility of 3&#x2032;-N-substituted derivatives of AmB, they transformed compounds 3, 6, and 7 into the corresponding C16-2-(N, N-dimethylamino) ethylamides (DMAE-amides). The water solubility of C-16-DMAE-amides was excellent (For scheme, Please refer to article) [<xref ref-type="bibr" rid="r39">39</xref>].</p>
               
                <p>Thanki <italic>et al</italic>. disclosed the AmB-lipid conjugate [AmB-oleyl conjugate (AmB-OA)] that enhances gastric stability (stable at stomach pH) &#x0026; permeability (greater penetration through Caco-2 monolayer) for increasing bioavailability. This conjugate was identical to the parent AmB. This conjugate also interacts with Saccharomyces cerevisiae internal membranes, but AmB interacts only with the plasma membrane. The <italic>in-vivo</italic> PK studies showed that AmB-OA had a 3.13-fold increase in Cmax and a 4.88-fold rise in AUCTot compared to AmB [<xref ref-type="bibr" rid="r61">61</xref>].</p>
                <p>Zhang <italic>et al</italic>. reported the novel AmB derivatives with greater therapeutic effect, diminished toxicity, and aqueous solubility. They checked nine N-substituted AmB derivatives for antimycotic activity by employing the broth dilution method and hemolytic toxicity using defibrinated sheep blood. The desired molecule, NH<sub>2</sub>-(AEEA)5-AmB (DMR 005; AEEA is 8-amino-3,6- dioxaoctanoic acid), was obtained after screening derivatives against two reference Candida albicans strains. So DMR005 showed good aqueous solubility, reduced toxicity, and retained antimycotic efficacy (For synthetic scheme, please refer to article) [<xref ref-type="bibr" rid="r62">62</xref>].</p>
                <p>Tevyashova <italic>et al</italic>. synthesized the C16-modified AmB derivatives (Scheme <bold><xref ref-type="scheme" rid="s3">3</xref></bold>). Out of all these derivatives, amphamide derivative showed drug-like properties, enhanced efficiency, improved safety, and more potency than AmB. The amphamide had shown lower acute toxicity and higher antifungal efficiency in the model of mice candidosis sepsis compared to AmB after performing electrophysiological and pharmacological studies. And it occurred possibly due to lower self-aggregation. And it has shown more excellent solubility [<xref ref-type="bibr" rid="r63">63</xref>].</p>
                <p>The summary of the above approach through the author&#x2019;s contribution is given in Table <bold><xref ref-type="table" rid="t3">3</xref></bold>.</p>
            </sec>
            <sec id="sec2.4">
                <label>2.4</label>
                <title>The Chemical Modification Approach of Amphotericin B for the Reduction in Toxicity</title>
                <p>V.V. Belakhov <italic>et al</italic>. prepared N-Benzyl compounds of AmB with high antimycotic activity, confirmed by evaluating physicochemical and biological properties and three times less toxicity than AmB. These compounds were prepared by condensing benzaldehydes with the primary amine of glycone part of AmB that produces azomethine. And this azomethine was reacted with cyanoborohydride by reductive amination to furnish AmB derivatives (For scheme, please refer to article) [<xref ref-type="bibr" rid="r15">15</xref>].</p>
                <table-wrap id="t3" position="float">
                    <label>Table 3</label>
                    <caption>
                        <title>The summary of the chemical modification approach of Amphotericin B for bioavailability improvement.</title>
                    </caption>
                    <table frame="border" rules="all" width="100%">
                        <thead>
                            <tr>
                                <th valign="middle" align="center" scope="col">
                                    <bold>S. No.</bold>
                                </th>
                                <th valign="middle" align="center" scope="col">
                                    <bold>Authors</bold>
                                </th>
                                <th valign="middle" align="center" scope="col">
                                    <bold>Contribution</bold>
                                </th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td valign="middle" align="center" scope="row">1</td>
                                <td valign="middle" align="center">Adediran <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Greatly water dissolving N-alkylguanidine/N-acylurea bis-adduct of AmB was obtained by reaction of Amphotericin B in DMF with bis(dimethylamino propyl)carbodiimide&#x201D; [<xref ref-type="bibr" rid="r33">33</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">2</td>
                                <td valign="middle" align="center">Nicolaou <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Reported the series of protected derivatives of AmB&#x201D; [<xref ref-type="bibr" rid="r57">57</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">3</td>
                                <td valign="middle" align="center">Arthur G. Mohan and co-worker Somerville, N. J.</td>
                                <td valign="middle" align="center">&#x201C;The strategies for synthesizing immense purity alkyl esters of polyene macrolide antibiotics&#x201D; [<xref ref-type="bibr" rid="r10">10</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">4</td>
                                <td valign="middle" align="center">Chang, Conway, C., <italic>et al</italic>. (WO 01/91758 Al)</td>
                                <td valign="middle" align="center">&#x201C;The two novel categories of amide derivatives of polyene macrolide with greater water solubility than native AmB &#x0026; amphotericin B methyl ester (AME) beneficial towards mycotic infections&#x201D; [<xref ref-type="bibr" rid="r32">32</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">5</td>
                                <td valign="middle" align="center">Elgart <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;The alteration in the distribution of AmB when conjugated to AG corresponds to the molecular weight of the conjugated polysaccharide&#x201D; [<xref ref-type="bibr" rid="r58">58</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">6</td>
                                <td valign="middle" align="center">Day <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Disclosed the application of pyridoxal phosphate (PLP) for achieving excellent solubilization of AmB&#x201D; [<xref ref-type="bibr" rid="r41">41</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">7</td>
                                <td valign="middle" align="center">Abeer <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Amphotericin-B can form non-covalent complexes with Poly(&#x03B1;-glutamic acid)&#x201D; [<xref ref-type="bibr" rid="r59">59</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">8</td>
                                <td valign="middle" align="center">Borowski, <italic>et al</italic>. <break/>(WO 2013/186384)</td>
                                <td valign="middle" align="center">&#x201C;Reported the semisynthetic N-substituted derivatives of AmB and water-soluble salts &#x0026; complexes&#x201D; [<xref ref-type="bibr" rid="r60">60</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">9</td>
                                <td valign="middle" align="center">V.V. Belakhov <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Introduction of phosphoryl group significantly increased the solubility of prepared derivatives&#x201D; [<xref ref-type="bibr" rid="r19">19</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">10</td>
                                <td valign="middle" align="center">Antillon <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Reported the novel L-histidine methyl ester of Amphotericin B (A21) derivative with improved selectivity&#x201D; [<xref ref-type="bibr" rid="r20">20</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">11</td>
                                <td valign="middle" align="center">Tevyashova <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Reported amide derivatives which showed good water solubility&#x201D; [<xref ref-type="bibr" rid="r39">39</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">12</td>
                                <td valign="middle" align="center">Kaushik Thanki <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Disclosed the AmB-lipid conjugate [AmB-oleyl conjugate (AmB-OA)], that enhances gastric stability (stable at stomach pH) &#x0026; permeability (greater penetration through Caco-2 monolayer) for increasing bioavailability&#x201D; [<xref ref-type="bibr" rid="r61">61</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">13</td>
                                <td valign="middle" align="center">Zhang <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Reported the novel AmB derivatives with greater therapeutic effect, diminished toxicity, and aqueous solubility&#x201D; [<xref ref-type="bibr" rid="r62">62</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">14</td>
                                <td valign="middle" align="center">Tevyashova <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Synthesized the C16-modified AmB derivatives. Out of all these derivatives, amphamide derivative showed drug-like properties, enhanced efficiency, improved safety, and more potency than AmB&#x201D; [<xref ref-type="bibr" rid="r63">63</xref>].</td>
                            </tr>
                        </tbody>
                    </table>
                </table-wrap>
                <p>The international patent number WO 2007/096137 Al disclosed the novel polyene macrolide compounds possessing diminished toxicity and more excellent antimycotic activity than Amphotericin B. The backbone of these compounds should contain one doubly alkylated free amino group, as shown in formula I. In a particular incarnation, this invention affords polyene macrolide derivatives as per formula II. Other formulae are also given in this patent. So, for all other formulae (Please refer to patent) [<xref ref-type="bibr" rid="r64">64</xref>].</p>
                <p><inline-graphic xlink:href="CTMC-22-19-1571-i6"/></p>
                <p>The international patent WO 2015/054148 Al reported that certain derivatives of amphotericin B (AmB) are characterized by reduced toxicity and retained antifungal activity. Some of the compounds are C16 urea derivatives of AmB, while others are C3, C5, C8, C9, C11, C13, or C15 deoxy derivatives of AmB, as well as C3&#x0027; or C4&#x0027; alterations of AmB&#x0027;s mycosamine appendage. It also included infor- mation on how to make AmB derivatives of the invention, pharmaceutical compositions using AmB derivatives of the invention, and ways to use AmB derivatives of the invention (For methods, please refer to patent) [<xref ref-type="bibr" rid="r65">65</xref>].</p>
                <p>The international patent WO 2016/112260 Al reported the derivatives of Amphotericin-B (AmB) with reduced toxicity and retained antifungal activity. Some of the derivatives are C16 urea derivatives and C16 carbamate of AmB. Also provided are the methods of making the AmB derivatives (For methods, please refer to patent) [<xref ref-type="bibr" rid="r66">66</xref>].</p>
                <p>The international patent WO 2016/112243Al reported the urea compounds of AmB with enhanced efficacy and diminished toxicity compared to AmB and useful against mycotic infections. The urea derivatives of AmB can be obtained according to formula I, where R represents methyl, ethyl, propyl, or isopropyl; R&#x0027; represents methyl, ethyl, propyl, or isopropyl; else, R and R&#x2019; can be taken together attaching to the nitrogen atom, represent a radical of a cyclic secondary amine. It also provided the methods for making the urea derivatives of AmB [<xref ref-type="bibr" rid="r67">67</xref>].</p>
                <p><inline-graphic xlink:href="CTMC-22-19-1571-i7"/></p>
                <p>The international patent WO 2016/061437Al to disclosed the C2&#x0027;epiAmB, an more efficacious derivative with diminished toxicity than amphotericin B (AmB), obtained by method constituted by series of individual methods (For methods, please refer to patent) [<xref ref-type="bibr" rid="r68">68</xref>]. Stephen A Davis <italic>et al</italic>. reported the less toxic amphotericins that nevertheless evade resistance and bind their target with far greater selectivity than AmB [<xref ref-type="bibr" rid="r69">69</xref>].</p>
                <p><inline-graphic xlink:href="CTMC-22-19-1571-i8"/></p>
                <p>Skwarecki <italic>et al</italic>. reported the conjugation of AmB with diwalled &#x201C;molecular umbrellas&#x201D; containing spermidine-linked deoxycholic or cholic acids through the &#x03C9;-amino acid linkers. This conjugate showed diminished toxicity, particularly hemolytic activity with improved antimycotic activity due to &#x201C;umbrella&#x201D; substituents. It did not correlate with the aggregation state [<xref ref-type="bibr" rid="r40">40</xref>].</p>
                <p>The summary of the above approach through the author&#x2019;s contribution is given in Table <bold><xref ref-type="table" rid="t4">4</xref></bold>.</p>
            </sec>
            <sec id="sec2.5">
                <label>2.5</label>
                <title>The Chemical Modification Approach of Amphotericin-B with Conjugated Drug Carriers</title>
                <p>Polyethylene glycol is a linear amphiphilic polymer accessed by condensing ethylene oxide monomer with the general formula HO (CH<sub>2</sub>-CH<sub>2</sub>O) nH. It does not possess biodegradability, toxicity, and immunogenicity. It is employed in protein and small molecule modification. The attachment site for PEG in the Amphotericin-B molecule is the amine part. Conover C. D. <italic>et al</italic>. reported the two methods for PEG conjugation through the controlled release of amino groups. Of these two methods, the 1, 6-benzyl elimination system is more common (For more detail, please refer to the article) [<xref ref-type="bibr" rid="r70">70</xref>, <xref ref-type="bibr" rid="r71">71</xref>].</p>
                <p>&#x201C;For the enhancement in the therapeutic efficacy of AmB, the polymeric carriers like polysaccharides, PEG, poly (ethylene glycol)-&#x03B2;-poly (L-lysine) can be attached with conjugates. The rate of release of AmB is controlled by the pH of the environment and the replacement of the benzene ring connected to the polymeric carrier&#x201D; (acid-catalyzed hydrolysis of imine linkage) [<xref ref-type="bibr" rid="r72">72</xref>].</p>
                <p>Larch arabinogalactans (AG) are employed as an attractive potential drug carrier due to their excellent aqueous solubility, biocompatibility, biodegradability, and flexibility of drug conjugation [<xref ref-type="bibr" rid="r58">58</xref>]. Polymer is not distributed systemically throughout the body, so it possesses the ability to reduce drug toxicity. In two ways, the diminished solubility of drugs can be enhanced by covalent conjugation or non-covalent association. Generally, covalent complexes are preferred to avoid chemical modification [<xref ref-type="bibr" rid="r59">59</xref>]. Amphotericin-B is available as Fungizone, Amphocin, Abelcet, and Ambisome with drug carriers [<xref ref-type="bibr" rid="r14">14</xref>].</p>
                <p>The C-H activated one-step oligomerization technology, developed by changing the molar ratio between two co-monomers, could extend oligomer libraries. As a result, the chasm between conjugated polymers and tiny molecules may be bridged [<xref ref-type="bibr" rid="r73">73</xref>]. TPE-DPP4 and BP-DPP4 are two novel diketopyrrolopyrrolopyrrol (DPP) based &#x03C0;-conjugated oligomers that were easily synthesized using a ligand-free Pd-catalyzed sequential activation of the C-H bond in two steps with good yields starting from simple building blocks for exploring sustainable chemistry for renewable energy [<xref ref-type="bibr" rid="r74">74</xref>].</p>
                <p>Nanotechnology plays a crucial role in the formation of drug delivery carriers for improvement in efficacy, lowering toxicity, and increasing the biocompatibility of drugs. The lipid-based nanocarriers are more in trend for AmB therapy as fungizone. Liposomal formulation (AmBisome) can diminish the nephrotoxicity associated with AmB. The prodrug technique of drug-lipid conjugates is used to tailor the physicochemical properties of the drug, which results in the improvement of GI permeability, gastric stability, and ultimately, poor bioavailability of drugs [<xref ref-type="bibr" rid="r61">61</xref>].</p>
                <p>Sedlak <italic>et al</italic>. reported the preparation and characte- rization of &#x201C;AmB-star polyethylene glycol (AmB-sPEG) conjugate&#x201D; of AmB having a molecular weight of 25,160 with target-specific characteristics. It also possesses a &#x03B2;-D-glucopyranoside molecular switch sensitive to &#x03B2;-gluco- sidases, which is responsible for the release of AmB, and it was confirmed <italic>in vitro</italic> by spectrophotometry and HPLC (For schemes, please refer to article) [<xref ref-type="bibr" rid="r72">72</xref>].</p>
                <p>Halperin <italic>et al</italic>. disclosed the two new PEG amide conjugates of amphotericin B, AB1, and AM2 with stable attributes. These conjugates showed antimycotic activity against a broad range of clinical fungal isolates, as confirmed by <italic>in vivo</italic> studies in a mouse model of systemic candidiasis. These can be formulated in two or three synthetic steps only. These possess diminished toxicity and aqueous solubility up to 5000-fold greater than AmB. In solubility studies, AB1 showed greater than 5000 more solubilities than AmB, and AM2 showed greater than 700 more solubilities than AmB. It indicates that the methyl-ester group that replaced AmB&#x0027;s carboxyl group in AM2 causes it to be more inadequate water-soluble than AB1. (For schemes, tables, and figures, please refer to the article) [<xref ref-type="bibr" rid="r7">7</xref>].</p>
                <table-wrap id="t4" position="float">
                    <label>Table 4</label>
                    <caption>
                        <title>The summary of the chemical modification approach for the reduction in toxicity of Amphotericin-B.</title>
                    </caption>
                    <table frame="border" rules="all" width="100%">
                        <thead>
                            <tr>
                                <th valign="middle" align="center" scope="col">
                                    <bold>S. No.</bold>
                                </th>
                                <th valign="middle" align="center" scope="col">
                                    <bold>Authors</bold>
                                </th>
                                <th valign="middle" align="center" scope="col">
                                    <bold>Contribution</bold>
                                </th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td valign="middle" align="center" scope="row">1</td>
                                <td valign="middle" align="center">Belakhov V.V. <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Prepared N-Benzyl compounds of AmB with high antimycotic activity, confirmed by evaluating physicochemical and biological properties and three times less toxicity than AmB&#x201D; [<xref ref-type="bibr" rid="r15">15</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">2</td>
                                <td valign="middle" align="center">Carreira and <italic>et al</italic>. (WO2007/096137Al)</td>
                                <td valign="middle" align="center">&#x201C;Disclosed the novel polyene macrolide compounds possessing diminished toxicity and more excellent antimycotic activity than Amphotericin B&#x201D; [<xref ref-type="bibr" rid="r64">64</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">3</td>
                                <td valign="middle" align="center">Stephen A Davis <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Reported the less toxic amphotericins that nevertheless evade resistance&#x201D; [<xref ref-type="bibr" rid="r69">69</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">4</td>
                                <td valign="middle" align="center">Burke Martin D. <italic>et al</italic>. (WO2015/054148Al)</td>
                                <td valign="middle" align="center">&#x201C;Reported the certain derivatives of amphotericin B (AmB) characterized by reduced toxicity and retained antifungal activity&#x201D; [<xref ref-type="bibr" rid="r65">65</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">5</td>
                                <td valign="middle" align="center">Burke Martin D. and Davis, Stephen (WO 2016/112260 Al)</td>
                                <td valign="middle" align="center">&#x201C;Reported the derivatives of amphotericin B (AmB) with reduced toxicity and retained antifungal activity&#x201D; [<xref ref-type="bibr" rid="r66">66</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">6</td>
                                <td valign="middle" align="center">Burke Martin D. (WO2016/112243Al)</td>
                                <td valign="middle" align="center">&#x201C;Reported the urea compounds of AmB with enhanced efficacy, diminished toxicity compared to AmB, and useful against mycotic infections&#x201D; [<xref ref-type="bibr" rid="r67">67</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">7</td>
                                <td valign="middle" align="center">Burke Martin D. (WO2016/061437Al)</td>
                                <td valign="middle" align="center">&#x201C;Disclosed the C2&#x0027;epiAmB, an more efficacious derivative with diminished toxicity than amphotericin B (AmB) obtained by method constituted by series of individual methods&#x201D; [<xref ref-type="bibr" rid="r68">68</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">8</td>
                                <td valign="middle" align="center">Andrzej S. Skwarecki <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Reported the conjugation of AmB with diwalled &#x201C;molecular umbrellas&#x201D; containing spermidine-linked deoxycholic or cholic acids through the &#x03C9;-amino acid linkers&#x201D; [<xref ref-type="bibr" rid="r40">40</xref>].</td>
                            </tr>
                        </tbody>
                    </table>
                </table-wrap>
                <table-wrap id="t5" position="float">
                    <label>Table 5</label>
                    <caption>
                        <title>The summary of the chemical modification approach of Amphotericin B with conjugated drug carriers.</title>
                    </caption>
                    <table frame="border" rules="all" width="100%">
                        <thead>
                            <tr>
                                <th valign="middle" align="center" scope="col">
                                    <bold>S. No.</bold>
                                </th>
                                <th valign="middle" align="center" scope="col">
                                    <bold>Authors</bold>
                                </th>
                                <th valign="middle" align="center" scope="col">
                                    <bold>Contribution</bold>
                                </th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td valign="middle" align="center" scope="row">1</td>
                                <td valign="middle" align="center">Conover C. D. <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Reported the two methods for PEG conjugation through the controlled release of amino groups&#x201D; [<xref ref-type="bibr" rid="r70">70</xref>, <xref ref-type="bibr" rid="r71">71</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">2</td>
                                <td valign="middle" align="center">Milos Sedlak <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Reported the preparation and characterization of &#x201C;AmB-star polyethylene glycol (AmB-sPEG) conjugate&#x201D; of AmB having molecular weight 25,160 with target-specific characteristics&#x201D; [<xref ref-type="bibr" rid="r72">72</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">3</td>
                                <td valign="middle" align="center">Assaf Halperin <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Disclosed the two new PEG amide conjugates of amphotericin B, AB1, and AM2 with stable attributes&#x201D; [<xref ref-type="bibr" rid="r7">7</xref>].</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">4</td>
                                <td valign="middle" align="center">Jean C. Villamil <italic>et al</italic>.</td>
                                <td valign="middle" align="center">&#x201C;Investigated the effect of mPEG-b-PCL conjugate with cholesterol&#x201D; [<xref ref-type="bibr" rid="r76">76</xref>].</td>
                            </tr>
                        </tbody>
                    </table>
                </table-wrap>
                <p>During the examination of Halogen-bonded complexes: CF3X....A(CH3)n, where X = Cl, Br, I; A = N, P, O, S; and n = 0, 1, 2, 3, the steric energy contributes less to the total interaction energy [<xref ref-type="bibr" rid="r75">75</xref>].</p>
                <p>Villamil <italic>et al</italic>. investigated the effect of mPEG-b-PCL conjugate with cholesterol. It is a biodegradable and biocompatible block co-polymer used as a drug carrier. The cholesterol enhanced the encapsulation efficiency and loading capacity of AmB, and improved the controlled release characteristics [<xref ref-type="bibr" rid="r76">76</xref>].</p>
                <p>The summary of the above approach through the author&#x2019;s contribution is given in Table <bold><xref ref-type="table" rid="t5">5</xref></bold>.</p>
            </sec>
        </sec>
        <sec id="sec3" sec-type="other2">
            <label>3</label>
            <title>Drug Delivery Approaches of Amphotericin-B</title>
            <p>This section comprises <italic>fourteen approaches</italic> applicable in the delivery of Amphotericin B.</p>
            <sec id="sec3.1">
                <label>3.1</label>
                <title>Solid Lipid Nano-particles (SLNs)</title>
                <p>Manisha and her co-worker attained the excellent oral bioavailability and diminished toxicity of AmB by forming SLNs filled with AmB. These SLNs maintained the AmB in its monomeric form for ergosterol binding because its dimeric form binds with cholesterol, which is responsible for toxicity enhancement. A sonication-aided nanoprecipitation technique developed these particles [<xref ref-type="bibr" rid="r77">77</xref>]. Butani and a co-worker had also prepared the SLN of Amphotericin B [<xref ref-type="bibr" rid="r78">78</xref>].</p>
            </sec>
            <sec id="sec3.2">
                <label>3.2</label>
                <title>PLGA-PEG Nanoparticles</title>
                <p>For the delivery of monomeric AmB, Mahasen <italic>et al</italic>. prepared the nanoparticle formulation containing a poly (lactide-co-glycolide)-poly (ethylene glycol) (PLGA-PEG) co-polymer filled with AmB &#x0026; glycyrrhizic acid as an absorption promoter. This formulation showed excellent antimycotic activity in <italic>in-vitro</italic> studies against Candida albicans and improved bioavailability than AmB in pharmacokinetic evaluation. Kumar <italic>et al</italic>. reported this formulation against Leishmania donovani in hamsters with more significant inhibition than the free AmB group [<xref ref-type="bibr" rid="r79">79</xref>, <xref ref-type="bibr" rid="r80">80</xref>]. Bushra T. AL-Quadeib <italic>et al</italic>. also reported the PLGA-PEG co-polymer as a drug delivery agent for nano-formulation of Amphotericin B [<xref ref-type="bibr" rid="r81">81</xref>].</p>
            </sec>
            <sec id="sec3.3">
                <label>3.3</label>
                <title>Nanostructured Lipid Carriers</title>
                <p>Janet <italic>et al</italic>. reported the preparation of nanostructured lipid carriers (NLC) for improvement in oral bioavailability of AmB &#x0026; reduction in toxicity through delivery in monomeric form. It comprises a blend of solid lipids &#x0026; lipidic oils and an additional chitosan coating for mucoadhesion to enhance lymphatic delivery [<xref ref-type="bibr" rid="r82">82</xref>]. Bavani Subramaniam and a co-worker also reported the nanostructured lipid carrier (NLC) for AmB delivery [<xref ref-type="bibr" rid="r83">83</xref>].</p>
            </sec>
            <sec id="sec3.4">
                <label>3.4</label>
                <title>Polymeric Micelles</title>
                <p>Ying <italic>et al</italic>. reported a micellar formulation having self-assembling property for oral delivery of AmB. This formulation was prepared by the thin-film method by loading AmB in a micellar system of lecithin-based mixed polymers. It enhances the solubility of AmB, improves oral bioavailability, and diminishes toxicity than fungizone [<xref ref-type="bibr" rid="r84">84</xref>]. Wang <italic>et al</italic>. also reported the polymeric micelles for AmB delivery [<xref ref-type="bibr" rid="r85">85</xref>].</p>
            </sec>
            <sec id="sec3.5">
                <label>3.5</label>
                <title>Oil in Water Micro Emulsion</title>
                <p>Acarilia <italic>et al</italic>. reported the oil in water (O/W) micro emulsion of AmB formulation to enhance solubility and reduce toxicity compared to the parent drug. This formulation consists of a blend of tween 80 &#x0026; span 80, having an HLB value of 13, and capryol PGMC as an oil phase composition [<xref ref-type="bibr" rid="r86">86</xref>].</p>
            </sec>
            <sec id="sec3.6">
                <label>3.6</label>
                <title>Pickering Emulsion</title>
                <p>Pickering emulsion is an emulsion with solid particles instead of surfactants for internal phase stabilization. Richter <italic>et al</italic>. prepared the Pickering emulsion filled with AmB. The cashew tree gum was grafted with polylactide nanoparticles used to stabilize this formulation. It showed excellent incorporation efficiency without excess aggregation [<xref ref-type="bibr" rid="r87">87</xref>].</p>
            </sec>
            <sec id="sec3.7">
                <label>3.7</label>
                <title>Chitosan and Porphyrin Polymeric Nanocarrier</title>
                <p>Bhatia <italic>et al</italic>. reported the biodegradable polymeric nanocarrier made up of oppositely charged chitosan and porphyrin, representing a polyelectrolyte complex to load AmB. This complex possesses diminished degradation in SGF and releases AmB than parent AmB confirmed by stability studies. An <italic>in vitro</italic> study showed that this formulation has more antifungal activity than free AmB as measured by the IC<sub>50</sub> method. And it also showed less hemolytic toxicity compared to free AmB, confirmed by <italic>in vitro</italic> study [<xref ref-type="bibr" rid="r88">88</xref>].</p>
            </sec>
            <sec id="sec3.8">
                <label>3.8</label>
                <title>Co-polymer</title>
                <p>Mohamed and a co-worker prepared the formulation of a pH-sensitive co-polymer containing tragacanth and acrylic acid employing &#x03B3;-irradiation. It protects the drug in a simulated gastric fluid having acidic pH and releases it in an alkaline environment. The efficacy of (Trag/Aac)-AmB was similar to free AmB. This formulation showed less renal damage than free AmB [<xref ref-type="bibr" rid="r89">89</xref>]. Kingo Banshoya and co-authors have also reported the co-polymer of Amphotericin-B with styrene-maleic acid (For figure, Please refer to article) [<xref ref-type="bibr" rid="r90">90</xref>].</p>
            </sec>
            <sec id="sec3.9">
                <label>3.9</label>
                <title>Solid-self Nano Emulsifying Drug Delivery System (S-SNEDDS)</title>
                <p>Singh <italic>et al</italic>. used spray-dried covalently inter-connected EDTA-chitosan (micro-particles) to develop a new solid-Self Nano Emulsifying Drug delivery system for the oral formulation of AmB. In an aqueous condition, this formulation displayed the capability of self nano emulsification to generate a stable formulation [<xref ref-type="bibr" rid="r91">91</xref>].</p>
            </sec>
            <sec id="sec3.10">
                <label>3.10</label>
                <title>Cubosomes</title>
                <p>Yang <italic>et al</italic>. reported a cubosomal formulation for the delivery of AmB to overcome the problem of poor bioavailability &#x0026; prepared by SolEmuls technology. It showed no nephrotoxicity at 10-20 mg/kg doses in a small animal model. The oral bioavailability of cubosome formulation increased by 285% compared to Fungizone, as shown in pharmacokinetic results (See article for results) [<xref ref-type="bibr" rid="r92">92</xref>].</p>
            </sec>
            <sec id="sec3.11">
                <label>3.11</label>
                <title>Carbon Nanotubes</title>
                <p>Prajapati <italic>et al</italic>. disclosed the carbon nanotubes to develop an oral formulation of AmB, which is attached to AmB covalently. This formulation showed potent inhibition against the parasite in <italic>in-vivo</italic> studies [<xref ref-type="bibr" rid="r93">93</xref>]. Hang Sun and co-authors have reported the conjugate of Amphotericin-B with carbon nanotubes [<xref ref-type="bibr" rid="r94">94</xref>].</p>
            </sec>
            <sec id="sec3.12">
                <label>3.12</label>
                <title>GCPQ Nanoparticles</title>
                <p>Serrano <italic>et al</italic>. reported the quaternary ammonium palmitoyl glycol chitosan (GCPQ) nanoparticles encapsulating AmB to improve oral bioavailability along with site-specificity and non-toxicity. This formulation showed identical efficacy to the parent drug and improved dissolution in simulated GIF than AmB [<xref ref-type="bibr" rid="r95">95</xref>].</p>
            </sec>
            <sec id="sec3.13">
                <label>3.13</label>
                <title>Cochleates</title>
                <p>Zarif <italic>et al</italic>. reported the application of cochleate for AmB delivery against Candida infections. &#x201C;The cochleate is made up of solid lipid bilayers arranged in rolled-up sheets composed of phospholipid-cation precipitates, majorly phosphatidylserine and calcium respectively&#x201D;. It was prepared by the hydrogel method, protects AmB in GIT from degradation, and showed stability, site-specificity, and non-hemotoxicity confirmed by <italic>in-vitro</italic> evaluation [<xref ref-type="bibr" rid="r96">96</xref>, <xref ref-type="bibr" rid="r97">97</xref>].</p>
            </sec>
            <sec id="sec3.14">
                <label>3.14</label>
                <title>Self-emulsifying Drug Delivery System (SEDDS)</title>
                <p>Wasan <italic>et al</italic>. disclosed a self-emulsifying drug delivery system to enhance the bioavailability, reduce toxicity, stability, and anti-Leishmanial activity of AmB. It is a lipid-based formulation administered by oral route [<xref ref-type="bibr" rid="r98">98</xref>-<xref ref-type="bibr" rid="r101">101</xref>].</p>
                <p>The summarized flow chart of all approaches to delivery of Amphotericin-B is given below (Fig. <bold><xref ref-type="fig" rid="f11">11</xref></bold>).</p>
               
                <table-wrap id="t6" position="float">
                    <label>Table 6</label>
                    <caption>
                        <title>The physicochemical properties of Amphotericin-B.</title>
                    </caption>
                    <table frame="border" rules="all" width="100%">
                        <thead>
                            <tr>
                                <th valign="top" align="center" scope="col">
                                    <bold>S. No.</bold>
                                </th>
                                <th valign="top" align="center" scope="col">
                                    <bold>Parameters</bold>
                                </th>
                                <th valign="top" align="center" scope="col">
                                    <bold>Values</bold>
                                </th>
                                <th valign="top" align="center" scope="col">
                                    <bold>S. No.</bold>
                                </th>
                                <th valign="top" align="center" scope="col">
                                    <bold>Parameters</bold>
                                </th>
                                <th valign="top" align="center" scope="col">
                                    <bold>Values</bold>
                                </th>
                            </tr>
                        </thead>
                        <tbody>
                            <tr>
                                <td valign="middle" align="center" scope="row">1</td>
                                <td valign="top" align="center">HOMO</td>
                                <td valign="top" align="center">5.991 eV</td>
                                <td valign="middle" align="center">6</td>
                                <td valign="top" align="center">Electrophilicity Index (&#x03C9;)</td>
                                <td valign="top" align="center">2.837</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">2</td>
                                <td valign="top" align="center">LUMO</td>
                                <td valign="top" align="center">1.303 eV</td>
                                <td valign="middle" align="center">7</td>
                                <td valign="top" align="center">Chemical Potential (&#x03BC;)</td>
                                <td valign="top" align="center">4.678</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">3</td>
                                <td valign="top" align="center">Energy gap</td>
                                <td valign="top" align="center">4.678 eV</td>
                                <td valign="middle" align="center">8</td>
                                <td valign="top" align="center">Electronegativity (&#x03C7;)</td>
                                <td valign="top" align="center">3.647</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">4</td>
                                <td valign="top" align="center">Ionization potential (IP)</td>
                                <td valign="top" align="center">5.991 eV</td>
                                <td valign="middle" align="center">9</td>
                                <td valign="top" align="center">Hardness (&#x03B7;)</td>
                                <td valign="top" align="center">2.344</td>
                            </tr>
                            <tr>
                                <td valign="middle" align="center" scope="row">5</td>
                                <td valign="top" align="center">Electron affinity (EA)</td>
                                <td valign="top" align="center">1.303 eV</td>
                                <td valign="middle" align="center">10</td>
                                <td valign="top" align="center">Softness (S)</td>
                                <td valign="top" align="center">9.376</td>
                            </tr>
                        </tbody>
                    </table>
                </table-wrap>
            </sec>
        </sec>
        <sec id="sec4" sec-type="other3">
            <label>4</label>
            <title>The physicochemical characteristics of Amphotericin-B</title>
            <p>Although molecular acidity is one of the essential physicochemical parameters of a molecular system, accurate computation and prediction remains a challenge in the literature. Density functional reactivity theory uses numbers from the information-theoretic (IT) approach to provide a precise explanation of molecular acidity from an altogether new perspective [<xref ref-type="bibr" rid="r102">102</xref>].</p>
            <p>Sumathi <italic>et al</italic>. reported the various physicochemical characteristics of AmB in Table <bold><xref ref-type="table" rid="t6">6</xref></bold> [<xref ref-type="bibr" rid="r103">103</xref>].</p>
        </sec>
        <sec id="sec5" sec-type="discussion">
            <label>5</label>
            <title>DISCUSSION</title>
            <p>Amphotericin B exhibits antimycotic activity against various infections, mainly systemic mycotic infections, Visceral Leishmaniasis, and protozoal infections. Its framework is made up of glycone and aglycone components. The hydrophobic polyene part, hydrophilic polyhydroxy portion, and carboxyl modification site for subsequent modification are all present in the aglycone component. An amine modification site is present in the glycone component for future transformation. Its amphipathic nature causes it to assemble in a hydrous environment. The toxicity generally arises due to dimer formation. It acts by attaching to the ergosterol of fungal cells, responsible for leaking ions from the fungal cell membrane, leading to death. It also binds to cholesterol which is responsible for renal toxicity. It is generally not affected by common drug-resistant mechanisms like drug efflux pumps because it does not bind to the protein as other drugs, but it binds to the ergosterol [<xref ref-type="bibr" rid="r44">44</xref>]. The various formulation of AmB is available, as mentioned above, but all those have their limitations. In this article, we have discussed the detail of advancement in its research related to chemical modification and drug delivery approaches as reported by many authors.</p>
        </sec>
        <sec sec-type="conclusions">
            <title>CONCLUSION</title>
            <p>Many authors have reported their efforts to resolve the problem associated with Amphotericin B, and there is a need for a better outcome of the problem and finally for the permanent oral formulation of Amphotericin B as it is available in the intravenous formulation. Also, it is costly &#x0026; uneasy for administration purposes.</p>
        </sec>
    </body>
    <back>
        <glossary>
            <title>List of ABBREVIATIONS</title>
            <def-list>
                <def-item>
                    <term>&#x00B5; Mol</term>
                    <def>
                        <p>Micro Mole</p>
                    </def>
                </def-item>
                <def-item>
                    <term>AmB</term>
                    <def>
                        <p>Amphotericin-B</p>
                    </def>
                </def-item>
                <def-item>
                    <term>AME</term>
                    <def>
                        <p>Amphotericin-B Methyl Ester</p>
                    </def>
                </def-item>
                <def-item>
                    <term>BCS</term>
                    <def>
                        <p>Biopharmaceutics Classification System</p>
                    </def>
                </def-item>
                <def-item>
                    <term>CD</term>
                    <def>
                        <p>Circular Dichroism</p>
                    </def>
                </def-item>
                <def-item>
                    <term>Cho</term>
                    <def>
                        <p>Cholesterol</p>
                    </def>
                </def-item>
                <def-item>
                    <term>CSA</term>
                    <def>
                        <p>Camphor Sulphonic Acid</p>
                    </def>
                </def-item>
                <def-item>
                    <term>DMAE amides</term>
                    <def>
                        <p>Dimethylethanolamine</p>
                    </def>
                </def-item>
                <def-item>
                    <term>DMF</term>
                    <def>
                        <p>Dimethyl Formamide</p>
                    </def>
                </def-item>
                <def-item>
                    <term>DW</term>
                    <def>
                        <p>Distilled Water</p>
                    </def>
                </def-item>
                <def-item>
                    <term>EC<sub>50</sub></term>
                    <def>
                        <p>Half Maximal effective concentration</p>
                    </def>
                </def-item>
                <def-item>
                    <term>Erg</term>
                    <def>
                        <p>Ergosterol</p>
                    </def>
                </def-item>
                <def-item>
                    <term>H-M<sub>w</sub>AG</term>
                    <def>
                        <p>High Molecular weight Arabinogalactan</p>
                    </def>
                </def-item>
                <def-item>
                    <term>HPLC</term>
                    <def>
                        <p>High-Performance Liquid Chromatography</p>
                    </def>
                </def-item>
                <def-item>
                    <term>m Mol</term>
                    <def>
                        <p>Mili Mole</p>
                    </def>
                </def-item>
                <def-item>
                    <term>M</term>
                    <def>
                        <p>Molar</p>
                    </def>
                </def-item>
                <def-item>
                    <term>MIC</term>
                    <def>
                        <p>Minimum Inhibitory Concentration</p>
                    </def>
                </def-item>
                <def-item>
                    <term>NF-&#x03BA;B</term>
                    <def>
                        <p>Nuclear Factor Kappa light chain enhancer of activated B cells</p>
                    </def>
                </def-item>
                <def-item>
                    <term>NMR</term>
                    <def>
                        <p>Nuclear Magnetic Spectrum</p>
                    </def>
                </def-item>
                <def-item>
                    <term>NOE</term>
                    <def>
                        <p>Nuclear Overhauser Effect</p>
                    </def>
                </def-item>
                <def-item>
                    <term>PEG</term>
                    <def>
                        <p>Polyethylene Glycol</p>
                    </def>
                </def-item>
                <def-item>
                    <term>PLP</term>
                    <def>
                        <p>Pyridoxal phosphate</p>
                    </def>
                </def-item>
                <def-item>
                    <term>RBC</term>
                    <def>
                        <p>Red Blood Corpuscles</p>
                    </def>
                </def-item>
                <def-item>
                    <term>SS NMR</term>
                    <def>
                        <p>Solid State Nuclear Magnetic Resonance</p>
                    </def>
                </def-item>
                <def-item>
                    <term>TLR2</term>
                    <def>
                        <p>Toll-like Receptor 2</p>
                    </def>
                </def-item>
                <def-item>
                    <term>TLR4</term>
                    <def>
                        <p>Toll-like Receptor 4</p>
                    </def>
                </def-item>
                <def-item>
                    <term>UV</term>
                    <def>
                        <p>Ultra Violet</p>
                    </def>
                </def-item>
            </def-list>
        </glossary>
        <sec sec-type="competing-interests">
            <title>Consent for Publication</title>
            <p>Not applicable.</p>
        </sec>
        <sec sec-type="financial-disclosure">
            <title>FUNDING</title>
            <p>We are thankful to Department of Science and Technology-BRICs (DST/IMRCD/ BRICS/PILOTCall3/NanoDrug/&#x2028;2019) and the Department of Higher Education, Bhopal, MP, India and the Department of Pharmacy, Central University of Rajasthan, India for financial support.</p>
        </sec>
        <sec sec-type="competing-interests">
            <title>conflict of interest</title>
            <p>The authors declare no conflict of interest, financial or otherwise.</p>
        </sec>
        <ack>
            <title>AcknowledgEments</title>
            <p>The authors acknowledge the Department of Science and Technology-BRICs (DST/IMRCD/ BRICS/PILOTCall3/&#x2028;NanoDrug/2019) and the Department of Higher Education, Bhopal, MP, India for the financial support and the Department of Pharmacy, Central University of Rajasthan, India for financial and infrastructure support.</p>
        </ack>
        <ref-list ref-list-type="acs">
            <title>REFERENCES</title>
            <ref id="r1">
                <label>1</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Sampaio</surname>
                            <given-names>J.P.</given-names>
                        </name>
                        <name>
                            <surname>Gadanho</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Bauer</surname>
                            <given-names>R.</given-names>
                        </name>
                        <etal/>
                    </person-group>
                    <article-title>Taxonomic studies in the Microbotryomycetidae: Leucosporidium golubevii sp. nov., Leucosporidiella gen. nov. and the new orders Leucosporidiales and Sporidiobolales.</article-title>
                    <source>Mycol. Prog.</source>
                    <year>2003</year>
                    <volume>2</volume>
                    <fpage>53</fpage>
                    <lpage>68</lpage>
                    <pub-id pub-id-type="doi">10.1007/s11557-006-0044-5</pub-id>
                </element-citation>
            </ref>
            <ref id="r2">
                <label>2</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Sant</surname>
                            <given-names>D.G.</given-names>
                        </name>
                        <name>
                            <surname>Tupe</surname>
                            <given-names>S.G.</given-names>
                        </name>
                        <name>
                            <surname>Ramana</surname>
                            <given-names>C.V.</given-names>
                        </name>
                        <name>
                            <surname>Deshpande</surname>
                            <given-names>M.V.</given-names>
                        </name>
                    </person-group>
                    <article-title>Fungal cell membrane-promising drug target for antifungal therapy.</article-title>
                    <source>J. Appl. Microbiol.</source>
                    <year>2016</year>
                    <volume>121</volume>
                    <issue>6</issue>
                    <fpage>1498</fpage>
                    <lpage>1510</lpage>
                    <pub-id pub-id-type="doi">10.1111/jam.13301</pub-id> <pub-id pub-id-type="pmid"> 27667746</pub-id>
                </element-citation>
            </ref>
            <ref id="r3">
                <label>3</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Solovieva</surname>
                            <given-names>S.E.</given-names>
                        </name>
                        <name>
                            <surname>Olsufyeva</surname>
                            <given-names>E.N.</given-names>
                        </name>
                        <name>
                            <surname>Preobrazhenskaya</surname>
                            <given-names>M.N.</given-names>
                        </name>
                    </person-group>
                    <article-title>Chemical modification of antifungal polyene macrolide antibiotics.</article-title>
                    <source>Russ. Chem. Rev.</source>
                    <year>2011</year>
                    <volume>80</volume>
                    <issue>2</issue>
                    <fpage>103</fpage>
                    <lpage>126</lpage>
                    <pub-id pub-id-type="doi">10.1070/RC2011v080n02ABEH004145</pub-id>
                </element-citation>
            </ref>
            <ref id="r4">
                <label>4</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Hamill</surname>
                            <given-names>R.J.</given-names>
                        </name>
                        <name>
                            <surname>Amphotericin</surname>
                            <given-names>B.</given-names>
                        </name>
                    </person-group>
                    <article-title>Amphotericin B formulations: A comparative review of efficacy and toxicity.</article-title>
                    <source>Drugs</source>
                    <year>2013</year>
                    <volume>73</volume>
                    <issue>9</issue>
                    <fpage>919</fpage>
                    <lpage>934</lpage>
                    <pub-id pub-id-type="doi">10.1007/s40265-013-0069-4</pub-id> <pub-id pub-id-type="pmid"> 23729001</pub-id>
                </element-citation>
            </ref>
            <ref id="r5">
                <label>5</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Czerwi&#x0144;ski</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Grzybowska</surname>
                            <given-names>J.</given-names>
                        </name>
                        <name>
                            <surname>Borowski</surname>
                            <given-names>E.</given-names>
                        </name>
                    </person-group>
                    <article-title>N-dimethyl-] aminoacyl derivatives of polyene macrolide antibiotics.</article-title>
                    <source>J. Antibiot. (Tokyo)</source>
                    <year>1986</year>
                    <volume>39</volume>
                    <issue>7</issue>
                    <fpage>1025</fpage>
                    <lpage>1027</lpage>
                    <pub-id pub-id-type="doi">10.7164/antibiotics.39.1025</pub-id> <pub-id pub-id-type="pmid"> 3759647</pub-id>
                </element-citation>
            </ref>
            <ref id="r6">
                <label>6</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Omelchuk</surname>
                            <given-names>O.A.</given-names>
                        </name>
                        <name>
                            <surname>Tevyashova</surname>
                            <given-names>A.N.</given-names>
                        </name>
                        <name>
                            <surname>Shchekotikhin</surname>
                            <given-names>A.E.</given-names>
                        </name>
                    </person-group>
                    <article-title>Recent advances in antifungal drug discovery based on polyene macrolide antibiotics.</article-title>
                    <source>Russ. Chem. Rev.</source>
                    <year>2018</year>
                    <volume>87</volume>
                    <issue>12</issue>
                    <fpage>1206</fpage>
                    <lpage>1225</lpage>
                    <pub-id pub-id-type="doi">10.1070/RCR4841</pub-id>
                </element-citation>
            </ref>
            <ref id="r7">
                <label>7</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Halperin</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Shadkchan</surname>
                            <given-names>Y.</given-names>
                        </name>
                        <name>
                            <surname>Pisarevsky</surname>
                            <given-names>E.</given-names>
                        </name>
                        <name>
                            <surname>Szpilman</surname>
                            <given-names>A.M.</given-names>
                        </name>
                        <name>
                            <surname>Sandovsky</surname>
                            <given-names>H.</given-names>
                        </name>
                        <name>
                            <surname>Osherov</surname>
                            <given-names>N.</given-names>
                        </name>
                        <name>
                            <surname>Benhar</surname>
                            <given-names>I.</given-names>
                        </name>
                    </person-group>
                    <article-title>Novel water-soluble amphotericin B-PEG conjugates with low toxicity and potent in vivo efficacy.</article-title>
                    <source>J. Med. Chem.</source>
                    <year>2016</year>
                    <volume>59</volume>
                    <issue>3</issue>
                    <fpage>1197</fpage>
                    <lpage>1206</lpage>
                    <pub-id pub-id-type="doi">10.1021/acs.jmedchem.5b01862</pub-id> <pub-id pub-id-type="pmid"> 26816333</pub-id>
                </element-citation>
            </ref>
            <ref id="r8">
                <label>8</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Nicolaou</surname>
                            <given-names>K.C.</given-names>
                        </name>
                        <name>
                            <surname>Chakraborty</surname>
                            <given-names>T.K.</given-names>
                        </name>
                        <name>
                            <surname>Daines</surname>
                            <given-names>R.A.</given-names>
                        </name>
                        <name>
                            <surname>Simpkins</surname>
                            <given-names>N.S.</given-names>
                        </name>
                    </person-group>
                    <article-title>Retrosynthetic and synthetic chemistry on amphotericin B. Synthesis of C(1)-C(20) and C(21)-C(38) fragments and construction of the 38-membered macrocycle.</article-title>
                    <source>J. Chem. Soc. Chem. Commun.</source>
                    <year>1986</year>
                    <issue>5</issue>
                    <fpage>413</fpage>
                    <lpage>416</lpage>
                    <pub-id pub-id-type="doi">10.1039/C39860000413</pub-id>
                </element-citation>
            </ref>
            <ref id="r9">
                <label>9</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Yamaji</surname>
                            <given-names>N.</given-names>
                        </name>
                        <name>
                            <surname>Matsumori</surname>
                            <given-names>N.</given-names>
                        </name>
                        <name>
                            <surname>Matsuoka</surname>
                            <given-names>S.</given-names>
                        </name>
                        <name>
                            <surname>Oishi</surname>
                            <given-names>T.</given-names>
                        </name>
                        <name>
                            <surname>Murata</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Amphotericin</surname>
                            <given-names>B.</given-names>
                        </name>
                    </person-group>
                    <article-title>Amphotericin B dimers with bisamide linkage bearing powerful membrane-permeabilizing activity.</article-title>
                    <source>Org. Lett.</source>
                    <year>2002</year>
                    <volume>4</volume>
                    <issue>12</issue>
                    <fpage>2087</fpage>
                    <lpage>2089</lpage>
                    <pub-id pub-id-type="doi">10.1021/ol025982m</pub-id> <pub-id pub-id-type="pmid"> 12049524</pub-id>
                </element-citation>
            </ref>
            <ref id="r10">
                <label>10</label>
                <element-citation publication-type="other">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Mohan</surname>
                            <given-names>A.G.</given-names>
                        </name>
                    </person-group>
                    <article-title>Processes for preparing amphotericin B polyene macrolide schiff bases and their alkyl esters</article-title>
                    <patent>US5981721A.</patent>
                </element-citation>
            </ref>
            <ref id="r11">
                <label>11</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Matsumori</surname>
                            <given-names>N.</given-names>
                        </name>
                        <name>
                            <surname>Umegawa</surname>
                            <given-names>Y.</given-names>
                        </name>
                        <name>
                            <surname>Oishi</surname>
                            <given-names>T.</given-names>
                        </name>
                        <name>
                            <surname>Murata</surname>
                            <given-names>M.</given-names>
                        </name>
                    </person-group>
                    <article-title>Bioactive fluorinated derivative of amphotericin B.</article-title>
                    <source>Bioorg. Med. Chem. Lett.</source>
                    <year>2005</year>
                    <volume>15</volume>
                    <issue>15</issue>
                    <fpage>3565</fpage>
                    <lpage>3567</lpage>
                    <pub-id pub-id-type="doi">10.1016/j.bmcl.2005.05.058</pub-id> <pub-id pub-id-type="pmid"> 15963721</pub-id>
                </element-citation>
            </ref>
            <ref id="r12">
                <label>12</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Matsumori</surname>
                            <given-names>N.</given-names>
                        </name>
                        <name>
                            <surname>Sawada</surname>
                            <given-names>Y.</given-names>
                        </name>
                        <name>
                            <surname>Murata</surname>
                            <given-names>M.</given-names>
                        </name>
                    </person-group>
                    <article-title>Large molecular assembly of amphotericin B formed in ergosterol-containing membrane evidenced by solid-state NMR of intramolecular bridged derivative.</article-title>
                    <source>J. Am. Chem. Soc.</source>
                    <year>2006</year>
                    <volume>128</volume>
                    <issue>36</issue>
                    <fpage>11977</fpage>
                    <lpage>11984</lpage>
                    <pub-id pub-id-type="doi">10.1021/ja063433w</pub-id> <pub-id pub-id-type="pmid"> 16953639</pub-id>
                </element-citation>
            </ref>
            <ref id="r13">
                <label>13</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Matsumori</surname>
                            <given-names>N.</given-names>
                        </name>
                        <name>
                            <surname>Sawada</surname>
                            <given-names>Y.</given-names>
                        </name>
                        <name>
                            <surname>Murata</surname>
                            <given-names>M.</given-names>
                        </name>
                    </person-group>
                    <article-title>Mycosamine orientation of amphotericin B controlling interaction with ergosterol: Sterol-dependent activity of conformation-restricted derivatives with an amino-carbonyl bridge.</article-title>
                    <source>J. Am. Chem. Soc.</source>
                    <year>2005</year>
                    <volume>127</volume>
                    <issue>30</issue>
                    <fpage>10667</fpage>
                    <lpage>10675</lpage>
                    <pub-id pub-id-type="doi">10.1021/ja051597r</pub-id> <pub-id pub-id-type="pmid"> 16045354</pub-id>
                </element-citation>
            </ref>
            <ref id="r14">
                <label>14</label>
                <element-citation publication-type="other">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Burke</surname>
                            <given-names>M.</given-names>
                        </name>
                    </person-group>
                    <article-title>Amphotericin B derivative with reduced toxicity</article-title>
                    <patent>WO 2014/165676 Al,</patent>
                    <year>2014</year>
                </element-citation>
            </ref>
            <ref id="r15">
                <label>15</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Belakhov</surname>
                            <given-names>V.V.</given-names>
                        </name>
                        <name>
                            <surname>Shenin</surname>
                            <given-names>Y.D.</given-names>
                        </name>
                    </person-group>
                    <article-title>Synthesis and antifungal activity of N-benzyl derivatives of amphotericin B.</article-title>
                    <source>Pharm. Chem. J.</source>
                    <year>2007</year>
                    <volume>41</volume>
                    <issue>7</issue>
                    <fpage>362</fpage>
                    <lpage>366</lpage>
                    <pub-id pub-id-type="doi">10.1007/s11094-007-0082-6</pub-id>
                </element-citation>
            </ref>
            <ref id="r16">
                <label>16</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Paquet</surname>
                            <given-names>V.</given-names>
                        </name>
                        <name>
                            <surname>Volmer</surname>
                            <given-names>A.A.</given-names>
                        </name>
                        <name>
                            <surname>Carreira</surname>
                            <given-names>E.M.</given-names>
                        </name>
                    </person-group>
                    <article-title>Synthesis and in vitro biological properties of novel cationic derivatives of amphotericin B.</article-title>
                    <source>Chemistry</source>
                    <year>2008</year>
                    <volume>14</volume>
                    <issue>8</issue>
                    <fpage>2465</fpage>
                    <lpage>2481</lpage>
                    <pub-id pub-id-type="doi">10.1002/chem.200701237</pub-id> <pub-id pub-id-type="pmid"> 18196508</pub-id>
                </element-citation>
            </ref>
            <ref id="r17">
                <label>17</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Matsushita</surname>
                            <given-names>N.</given-names>
                        </name>
                        <name>
                            <surname>Matsuo</surname>
                            <given-names>Y.</given-names>
                        </name>
                        <name>
                            <surname>Tsuchikawa</surname>
                            <given-names>H.</given-names>
                        </name>
                        <name>
                            <surname>Matsumori</surname>
                            <given-names>N.</given-names>
                        </name>
                        <name>
                            <surname>Murata</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Oishi</surname>
                            <given-names>T.</given-names>
                        </name>
                    </person-group>
                    <article-title>Synthesis of 25- 13c-Amphotericin B methyl ester: A molecular probe for solid-state NMR measurements.</article-title>
                    <source>Chem. Lett.</source>
                    <year>2009</year>
                    <volume>38</volume>
                    <issue>2</issue>
                    <fpage>114</fpage>
                    <lpage>115</lpage>
                    <pub-id pub-id-type="doi">10.1246/cl.2009.114</pub-id>
                </element-citation>
            </ref>
            <ref id="r18">
                <label>18</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Croatt</surname>
                            <given-names>M.P.</given-names>
                        </name>
                        <name>
                            <surname>Carreira</surname>
                            <given-names>E.M.</given-names>
                        </name>
                    </person-group>
                    <article-title>Probing the role of the mycosamine C2&#x2032;-OH on the activity of amphotericin B.</article-title>
                    <source>Org. Lett.</source>
                    <year>2011</year>
                    <volume>13</volume>
                    <issue>6</issue>
                    <fpage>1390</fpage>
                    <lpage>1393</lpage>
                    <pub-id pub-id-type="doi">10.1021/ol2000765</pub-id> <pub-id pub-id-type="pmid"> 21322610</pub-id>
                </element-citation>
            </ref>
            <ref id="r19">
                <label>19</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Belakhov</surname>
                            <given-names>V.V.</given-names>
                        </name>
                        <name>
                            <surname>Kolodyaznaya</surname>
                            <given-names>V.A.</given-names>
                        </name>
                        <name>
                            <surname>Garabadzhiu</surname>
                            <given-names>A.V.</given-names>
                        </name>
                    </person-group>
                    <article-title>Chemical modification of heptaene macrolide antibiotic amphotericin b under conditions of the atherton-todd reaction.</article-title>
                    <source>Russ. J. Gen. Chem.</source>
                    <year>2014</year>
                    <volume>84</volume>
                    <issue>10</issue>
                    <fpage>1953</fpage>
                    <lpage>1961</lpage>
                    <pub-id pub-id-type="doi">10.1134/S107036321410017X</pub-id>
                </element-citation>
            </ref>
            <ref id="r20">
                <label>20</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Antill&#x00F3;n</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>de Vries</surname>
                            <given-names>A.H.</given-names>
                        </name>
                        <name>
                            <surname>Espinosa-Caballero</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Falc&#x00F3;n-Gonz&#x00E1;lez</surname>
                            <given-names>J.M.</given-names>
                        </name>
                        <name>
                            <surname>Flores Romero</surname>
                            <given-names>D.</given-names>
                        </name>
                        <name>
                            <surname>Gonz&#x00E1;lez-Dami&#x00E1;n</surname>
                            <given-names>J.</given-names>
                        </name>
                        <name>
                            <surname>Jim&#x00E9;nez-Montejo</surname>
                            <given-names>F.E.</given-names>
                        </name>
                        <name>
                            <surname>Le&#x00F3;n-Buitimea</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>L&#x00F3;pez-Ortiz</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Maga&#x00F1;a</surname>
                            <given-names>R.</given-names>
                        </name>
                        <name>
                            <surname>Marrink</surname>
                            <given-names>S.J.</given-names>
                        </name>
                        <name>
                            <surname>Morales-Nava</surname>
                            <given-names>R.</given-names>
                        </name>
                        <name>
                            <surname>Periole</surname>
                            <given-names>X.</given-names>
                        </name>
                        <name>
                            <surname>Reyes-Esparza</surname>
                            <given-names>J.</given-names>
                        </name>
                        <name>
                            <surname>Rodr&#x00ED;guez Lozada</surname>
                            <given-names>J.</given-names>
                        </name>
                        <name>
                            <surname>Santiago-Angelino</surname>
                            <given-names>T.M.</given-names>
                        </name>
                        <name>
                            <surname>Vargas Gonz&#x00E1;lez</surname>
                            <given-names>M.C.</given-names>
                        </name>
                        <name>
                            <surname>Regla</surname>
                            <given-names>I.</given-names>
                        </name>
                        <name>
                            <surname>Carrillo-Tripp</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Fern&#x00E1;ndez-Zertuche</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Rodr&#x00ED;guez-Fragoso</surname>
                            <given-names>L.</given-names>
                        </name>
                        <name>
                            <surname>Ortega-Blake</surname>
                            <given-names>I.</given-names>
                        </name>
                    </person-group>
                    <article-title>An amphotericin B derivative equally potent to amphotericin B and with increased safety.</article-title>
                    <source>PLoS One</source>
                    <year>2016</year>
                    <volume>11</volume>
                    <issue>9</issue>
                    <elocation-id>e0162171</elocation-id>
                    <pub-id pub-id-type="doi">10.1371/journal.pone.0162171</pub-id> <pub-id pub-id-type="pmid"> 27683101</pub-id>
                </element-citation>
            </ref>
            <ref id="r21">
                <label>21</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Sedl&#x00E1;k</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Amphotericin</surname>
                            <given-names>B.</given-names>
                        </name>
                        <name>
                            <surname>Amphotericin</surname>
                            <given-names>B.</given-names>
                        </name>
                    </person-group>
                    <article-title>From derivatives to covalent targeted conjugates.</article-title>
                    <source>Mini Rev. Med. Chem.</source>
                    <year>2009</year>
                    <volume>9</volume>
                    <issue>11</issue>
                    <fpage>1306</fpage>
                    <lpage>1316</lpage>
                    <pub-id pub-id-type="doi">10.2174/138955709789878178</pub-id> <pub-id pub-id-type="pmid"> 19929807</pub-id>
                </element-citation>
            </ref>
            <ref id="r22">
                <label>22</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Murata</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Kasai</surname>
                            <given-names>Y.</given-names>
                        </name>
                        <name>
                            <surname>Umegawa</surname>
                            <given-names>Y.</given-names>
                        </name>
                        <name>
                            <surname>Matsushita</surname>
                            <given-names>N.</given-names>
                        </name>
                        <name>
                            <surname>Tsuchikawa</surname>
                            <given-names>H.</given-names>
                        </name>
                        <name>
                            <surname>Matsumori</surname>
                            <given-names>N.</given-names>
                        </name>
                        <name>
                            <surname>Oishi</surname>
                            <given-names>T.</given-names>
                        </name>
                    </person-group>
                    <article-title>Ion channel complex of antibiotics as viewed by NMR.</article-title>
                    <source>Pure Appl. Chem.</source>
                    <year>2009</year>
                    <volume>81</volume>
                    <issue>6</issue>
                    <fpage>1123</fpage>
                    <lpage>1129</lpage>
                    <pub-id pub-id-type="doi">10.1351/PAC-CON-08-08-37</pub-id>
                </element-citation>
            </ref>
            <ref id="r23">
                <label>23</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Palacios</surname>
                            <given-names>D.S.</given-names>
                        </name>
                        <name>
                            <surname>Dailey</surname>
                            <given-names>I.</given-names>
                        </name>
                        <name>
                            <surname>Siebert</surname>
                            <given-names>D.M.</given-names>
                        </name>
                        <name>
                            <surname>Wilcock</surname>
                            <given-names>B.C.</given-names>
                        </name>
                        <name>
                            <surname>Burke</surname>
                            <given-names>M.D.</given-names>
                        </name>
                    </person-group>
                    <article-title>Synthesis-enabled functional group deletions reveal key underpinnings of amphotericin B ion channel and antifungal activities.</article-title>
                    <source>Proc. Natl. Acad. Sci. USA</source>
                    <year>2011</year>
                    <volume>108</volume>
                    <issue>17</issue>
                    <fpage>6733</fpage>
                    <lpage>6738</lpage>
                    <pub-id pub-id-type="doi">10.1073/pnas.1015023108</pub-id> <pub-id pub-id-type="pmid"> 21368185</pub-id>
                </element-citation>
            </ref>
            <ref id="r24">
                <label>24</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Szpilman</surname>
                            <given-names>A.M.</given-names>
                        </name>
                        <name>
                            <surname>Manthorpe</surname>
                            <given-names>J.M.</given-names>
                        </name>
                        <name>
                            <surname>Carreira</surname>
                            <given-names>E.M.</given-names>
                        </name>
                    </person-group>
                    <article-title>Synthesis and biological studies of 35-deoxy amphotericin B methyl ester.</article-title>
                    <source>Angew. Chem. Int. Ed. Engl.</source>
                    <year>2008</year>
                    <volume>47</volume>
                    <issue>23</issue>
                    <fpage>4339</fpage>
                    <lpage>4342</lpage>
                    <pub-id pub-id-type="doi">10.1002/anie.200800590</pub-id> <pub-id pub-id-type="pmid"> 18442156</pub-id>
                </element-citation>
            </ref>
            <ref id="r25">
                <label>25</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Zumbuehl</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Jeannerat</surname>
                            <given-names>D.</given-names>
                        </name>
                        <name>
                            <surname>Martin</surname>
                            <given-names>S.E.</given-names>
                        </name>
                        <name>
                            <surname>Sohrmann</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Stano</surname>
                            <given-names>P.</given-names>
                        </name>
                        <name>
                            <surname>Vigassy</surname>
                            <given-names>T.</given-names>
                        </name>
                        <name>
                            <surname>Clark</surname>
                            <given-names>D.D.</given-names>
                        </name>
                        <name>
                            <surname>Hussey</surname>
                            <given-names>S.L.</given-names>
                        </name>
                        <name>
                            <surname>Peter</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Peterson</surname>
                            <given-names>B.R.</given-names>
                        </name>
                        <name>
                            <surname>Pretsch</surname>
                            <given-names>E.</given-names>
                        </name>
                        <name>
                            <surname>Walde</surname>
                            <given-names>P.</given-names>
                        </name>
                        <name>
                            <surname>Carreira</surname>
                            <given-names>E.M.</given-names>
                        </name>
                    </person-group>
                    <article-title>An amphotericin B-fluorescein conjugate as a powerful probe for biochemical studies of the membrane.</article-title>
                    <source>Angew. Chem. Int. Ed.</source>
                    <year>2004</year>
                    <volume>43</volume>
                    <issue>39</issue>
                    <fpage>5181</fpage>
                    <lpage>5185</lpage>
                    <pub-id pub-id-type="doi">10.1002/anie.200460489</pub-id> <pub-id pub-id-type="pmid"> 15455425</pub-id>
                </element-citation>
            </ref>
            <ref id="r26">
                <label>26</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Gray</surname>
                            <given-names>K.C.</given-names>
                        </name>
                        <name>
                            <surname>Palacios</surname>
                            <given-names>D.S.</given-names>
                        </name>
                        <name>
                            <surname>Dailey</surname>
                            <given-names>I.</given-names>
                        </name>
                        <name>
                            <surname>Endo</surname>
                            <given-names>M.M.</given-names>
                        </name>
                        <name>
                            <surname>Uno</surname>
                            <given-names>B.E.</given-names>
                        </name>
                        <name>
                            <surname>Wilcock</surname>
                            <given-names>B.C.</given-names>
                        </name>
                        <name>
                            <surname>Burke</surname>
                            <given-names>M.D.</given-names>
                        </name>
                    </person-group>
                    <article-title>Amphotericin primarily kills yeast by simply binding ergosterol.</article-title>
                    <source>Proc. Natl. Acad. Sci. USA</source>
                    <year>2012</year>
                    <volume>109</volume>
                    <issue>7</issue>
                    <fpage>2234</fpage>
                    <lpage>2239</lpage>
                    <pub-id pub-id-type="doi">10.1073/pnas.1117280109</pub-id> <pub-id pub-id-type="pmid"> 22308411</pub-id>
                </element-citation>
            </ref>
            <ref id="r27">
                <label>27</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Matsumori</surname>
                            <given-names>N.</given-names>
                        </name>
                        <name>
                            <surname>Yamaji</surname>
                            <given-names>N.</given-names>
                        </name>
                        <name>
                            <surname>Matsuoka</surname>
                            <given-names>S.</given-names>
                        </name>
                        <name>
                            <surname>Oishi</surname>
                            <given-names>T.</given-names>
                        </name>
                        <name>
                            <surname>Murata</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Amphotericin</surname>
                            <given-names>B.</given-names>
                        </name>
                    </person-group>
                    <article-title>Amphotericin B covalent dimers forming sterol-dependent ion-permeable membrane channels.</article-title>
                    <source>J. Am. Chem. Soc.</source>
                    <year>2002</year>
                    <volume>124</volume>
                    <issue>16</issue>
                    <fpage>4180</fpage>
                    <lpage>4181</lpage>
                    <pub-id pub-id-type="doi">10.1021/ja012026b</pub-id> <pub-id pub-id-type="pmid"> 11960425</pub-id>
                </element-citation>
            </ref>
            <ref id="r28">
                <label>28</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Umegawa</surname>
                            <given-names>Y.</given-names>
                        </name>
                        <name>
                            <surname>Nakagawa</surname>
                            <given-names>Y.</given-names>
                        </name>
                        <name>
                            <surname>Tahara</surname>
                            <given-names>K.</given-names>
                        </name>
                        <name>
                            <surname>Tsuchikawa</surname>
                            <given-names>H.</given-names>
                        </name>
                        <name>
                            <surname>Matsumori</surname>
                            <given-names>N.</given-names>
                        </name>
                        <name>
                            <surname>Oishi</surname>
                            <given-names>T.</given-names>
                        </name>
                        <name>
                            <surname>Murata</surname>
                            <given-names>M.</given-names>
                        </name>
                    </person-group>
                    <article-title>Head-to-tail interaction between amphotericin B and ergosterol occurs in hydrated phospholipid membrane.</article-title>
                    <source>Biochemistry</source>
                    <year>2012</year>
                    <volume>51</volume>
                    <issue>1</issue>
                    <fpage>83</fpage>
                    <lpage>89</lpage>
                    <pub-id pub-id-type="doi">10.1021/bi2012542</pub-id> <pub-id pub-id-type="pmid"> 22129239</pub-id>
                </element-citation>
            </ref>
            <ref id="r29">
                <label>29</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Cuddihy</surname>
                            <given-names>G.</given-names>
                        </name>
                        <name>
                            <surname>Wasan</surname>
                            <given-names>E.K.</given-names>
                        </name>
                        <name>
                            <surname>Di</surname>
                            <given-names>Y.</given-names>
                        </name>
                        <name>
                            <surname>Wasan</surname>
                            <given-names>K.M.</given-names>
                        </name>
                    </person-group>
                    <article-title>The development of oral amphotericin B to treat systemic fungal and parasitic infections: Has the myth been finally realized?</article-title>
                    <source>Pharmaceutics</source>
                    <year>2019</year>
                    <volume>11</volume>
                    <issue>3</issue>
                    <elocation-id>E99</elocation-id>
                    <pub-id pub-id-type="doi">10.3390/pharmaceutics11030099</pub-id> <pub-id pub-id-type="pmid"> 30813569</pub-id>
                </element-citation>
            </ref>
            <ref id="r30">
                <label>30</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Tevyashova</surname>
                            <given-names>A.N.</given-names>
                        </name>
                        <name>
                            <surname>Olsufyeva</surname>
                            <given-names>E.N.</given-names>
                        </name>
                        <name>
                            <surname>Solovieva</surname>
                            <given-names>S.E.</given-names>
                        </name>
                        <name>
                            <surname>Printsevskaya</surname>
                            <given-names>S.S.</given-names>
                        </name>
                        <name>
                            <surname>Reznikova</surname>
                            <given-names>M.I.</given-names>
                        </name>
                        <name>
                            <surname>Trenin</surname>
                            <given-names>A.S.</given-names>
                        </name>
                        <name>
                            <surname>Galatenko</surname>
                            <given-names>O.A.</given-names>
                        </name>
                        <name>
                            <surname>Treshalin</surname>
                            <given-names>I.D.</given-names>
                        </name>
                        <name>
                            <surname>Pereverzeva</surname>
                            <given-names>E.R.</given-names>
                        </name>
                        <name>
                            <surname>Mirchink</surname>
                            <given-names>E.P.</given-names>
                        </name>
                        <name>
                            <surname>Isakova</surname>
                            <given-names>E.B.</given-names>
                        </name>
                        <name>
                            <surname>Zotchev</surname>
                            <given-names>S.B.</given-names>
                        </name>
                        <name>
                            <surname>Preobrazhenskaya</surname>
                            <given-names>M.N.</given-names>
                        </name>
                    </person-group>
                    <article-title>Structure-antifungal activity relationships of polyene antibiotics of the amphotericin B group.</article-title>
                    <source>Antimicrob. Agents Chemother.</source>
                    <year>2013</year>
                    <volume>57</volume>
                    <issue>8</issue>
                    <fpage>3815</fpage>
                    <lpage>3822</lpage>
                    <pub-id pub-id-type="doi">10.1128/AAC.00270-13</pub-id> <pub-id pub-id-type="pmid"> 23716057</pub-id>
                </element-citation>
            </ref>
            <ref id="r31">
                <label>31</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Serrano</surname>
                            <given-names>D.</given-names>
                        </name>
                        <name>
                            <surname>Ballesteros</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Sch&#x00E4;tzlein</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Torrado</surname>
                            <given-names>J.</given-names>
                        </name>
                        <name>
                            <surname>Uchegbu</surname>
                            <given-names>I.</given-names>
                        </name>
                        <name>
                            <surname>Amphotericin</surname>
                            <given-names>B.</given-names>
                        </name>
                    </person-group>
                    <article-title>Formulations &#x2013; The possibility of generic competition.</article-title>
                    <source>Pharm. Nanotechnol.</source>
                    <year>2013</year>
                    <volume>1</volume>
                    <issue>4</issue>
                    <fpage>250</fpage>
                    <lpage>258</lpage>
                    <pub-id pub-id-type="doi">10.2174/2211738501999131118125018</pub-id>
                </element-citation>
            </ref>
            <ref id="r32">
                <label>32</label>
                <element-citation publication-type="other">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Chang</surname>
                            <given-names>C.</given-names>
                        </name>
                    </person-group>
                    <article-title>Water-soluble amide derivatives of plyene macrolides
	and preparation and uses thereof</article-title>
                    <patent>WO/2001/091758</patent>
                    <year>2001</year>
                </element-citation>
            </ref>
            <ref id="r33">
                <label>33</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Adediran</surname>
                            <given-names>S.A.</given-names>
                        </name>
                        <name>
                            <surname>Day</surname>
                            <given-names>T.P.</given-names>
                        </name>
                        <name>
                            <surname>Sil</surname>
                            <given-names>D.</given-names>
                        </name>
                        <name>
                            <surname>Kimbrell</surname>
                            <given-names>M.R.</given-names>
                        </name>
                        <name>
                            <surname>Warshakoon</surname>
                            <given-names>H.J.</given-names>
                        </name>
                        <name>
                            <surname>Malladi</surname>
                            <given-names>S.S.</given-names>
                        </name>
                        <name>
                            <surname>David</surname>
                            <given-names>S.A.</given-names>
                        </name>
                    </person-group>
                    <article-title>Synthesis of a highly water-soluble derivative of amphotericin B with attenuated proinflammatory activity.</article-title>
                    <source>Mol. Pharm.</source>
                    <year>2009</year>
                    <volume>6</volume>
                    <issue>5</issue>
                    <fpage>1582</fpage>
                    <lpage>1590</lpage>
                    <pub-id pub-id-type="doi">10.1021/mp9001602</pub-id> <pub-id pub-id-type="pmid"> 19663403</pub-id>
                </element-citation>
            </ref>
            <ref id="r34">
                <label>34</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Szpilman</surname>
                            <given-names>A.M.</given-names>
                        </name>
                        <name>
                            <surname>Cereghetti</surname>
                            <given-names>D.M.</given-names>
                        </name>
                        <name>
                            <surname>Manthorpe</surname>
                            <given-names>J.M.</given-names>
                        </name>
                        <name>
                            <surname>Wurtz</surname>
                            <given-names>N.R.</given-names>
                        </name>
                        <name>
                            <surname>Carreira</surname>
                            <given-names>E.M.</given-names>
                        </name>
                    </person-group>
                    <article-title>Synthesis and biophysical studies on 35-deoxy amphotericin B methyl ester.</article-title>
                    <source>Chemistry</source>
                    <year>2009</year>
                    <volume>15</volume>
                    <issue>29</issue>
                    <fpage>7117</fpage>
                    <lpage>7128</lpage>
                    <pub-id pub-id-type="doi">10.1002/chem.200900231</pub-id> <pub-id pub-id-type="pmid"> 19544513</pub-id>
                </element-citation>
            </ref>
            <ref id="r35">
                <label>35</label>
                <element-citation publication-type="other">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Antill&#x00F3;n D&#x00ED;az</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Carrillo Tripp</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Fern&#x00E1;ndez-Zertuche</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Flores Moreno</surname>
                            <given-names>J.D.</given-names>
                        </name>
                        <name>
                            <surname>Jim&#x00E9;nez Montejo</surname>
                            <given-names>F.E.</given-names>
                        </name>
                        <name>
                            <surname>Le&#x00F3;n Buitimea</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Morales Nava</surname>
                            <given-names>R.</given-names>
                        </name>
                        <name>
                            <surname>Ocampo Mart&#x00ED;nez</surname>
                            <given-names>L.</given-names>
                        </name>
                        <name>
                            <surname>Ortega Blake</surname>
                            <given-names>I.</given-names>
                        </name>
                        <name>
                            <surname>Reyes Esparza</surname>
                            <given-names>J.A.</given-names>
                        </name>
                    </person-group>
                    <article-title>New amphotericin analogous compounds and pharmaceutical compositions containing them</article-title>
                    <patent>WO 2012/085784 A2</patent>
                    <year>2012</year>
                </element-citation>
            </ref>
            <ref id="r36">
                <label>36</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Wilcock</surname>
                            <given-names>B.C.</given-names>
                        </name>
                        <name>
                            <surname>Uno</surname>
                            <given-names>B.E.</given-names>
                        </name>
                        <name>
                            <surname>Bromann</surname>
                            <given-names>G.L.</given-names>
                        </name>
                        <name>
                            <surname>Clark</surname>
                            <given-names>M.J.</given-names>
                        </name>
                        <name>
                            <surname>Anderson</surname>
                            <given-names>T.M.</given-names>
                        </name>
                        <name>
                            <surname>Burke</surname>
                            <given-names>M.D.</given-names>
                        </name>
                    </person-group>
                    <article-title>Electronic tuning of site-selectivity.</article-title>
                    <source>Nat. Chem.</source>
                    <year>2012</year>
                    <volume>4</volume>
                    <issue>12</issue>
                    <fpage>996</fpage>
                    <lpage>1003</lpage>
                    <pub-id pub-id-type="doi">10.1038/nchem.1495</pub-id> <pub-id pub-id-type="pmid"> 23174979</pub-id>
                </element-citation>
            </ref>
            <ref id="r37">
                <label>37</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Tsuchikawa</surname>
                            <given-names>H.</given-names>
                        </name>
                        <name>
                            <surname>Matsushita</surname>
                            <given-names>N.</given-names>
                        </name>
                        <name>
                            <surname>Matsumori</surname>
                            <given-names>N.</given-names>
                        </name>
                        <name>
                            <surname>Murata</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Oishi</surname>
                            <given-names>T.</given-names>
                        </name>
                    </person-group>
                    <article-title>Synthesis of 28-19F-amphotericin B methyl ester.</article-title>
                    <source>Tetrahedron Lett.</source>
                    <year>2006</year>
                    <volume>47</volume>
                    <issue>35</issue>
                    <fpage>6187</fpage>
                    <lpage>6191</lpage>
                    <pub-id pub-id-type="doi">10.1016/j.tetlet.2006.06.159</pub-id>
                </element-citation>
            </ref>
            <ref id="r38">
                <label>38</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Kasai</surname>
                            <given-names>Y.</given-names>
                        </name>
                        <name>
                            <surname>Matsumori</surname>
                            <given-names>N.</given-names>
                        </name>
                        <name>
                            <surname>Umegawa</surname>
                            <given-names>Y.</given-names>
                        </name>
                        <name>
                            <surname>Matsuoka</surname>
                            <given-names>S.</given-names>
                        </name>
                        <name>
                            <surname>Ueno</surname>
                            <given-names>H.</given-names>
                        </name>
                        <name>
                            <surname>Ikeuchi</surname>
                            <given-names>H.</given-names>
                        </name>
                        <name>
                            <surname>Oishi</surname>
                            <given-names>T.</given-names>
                        </name>
                        <name>
                            <surname>Murata</surname>
                            <given-names>M.</given-names>
                        </name>
                    </person-group>
                    <article-title>Self-assembled amphotericin B is probably surrounded by ergosterol: Bimolecular interactions as evidenced by solid-state NMR and CD spectra.</article-title>
                    <source>Chemistry</source>
                    <year>2008</year>
                    <volume>14</volume>
                    <issue>4</issue>
                    <fpage>1178</fpage>
                    <lpage>1185</lpage>
                    <pub-id pub-id-type="doi">10.1002/chem.200701256</pub-id> <pub-id pub-id-type="pmid"> 17999396</pub-id>
                </element-citation>
            </ref>
            <ref id="r39">
                <label>39</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Tevyashova</surname>
                            <given-names>A.N.</given-names>
                        </name>
                        <name>
                            <surname>Korolev</surname>
                            <given-names>A.M.</given-names>
                        </name>
                        <name>
                            <surname>Trenin</surname>
                            <given-names>A.S.</given-names>
                        </name>
                        <name>
                            <surname>Dezhenkova</surname>
                            <given-names>L.G.</given-names>
                        </name>
                        <name>
                            <surname>Shtil</surname>
                            <given-names>A.A.</given-names>
                        </name>
                        <name>
                            <surname>Polshakov</surname>
                            <given-names>V.I.</given-names>
                        </name>
                        <name>
                            <surname>Savelyev</surname>
                            <given-names>O.Y.</given-names>
                        </name>
                        <name>
                            <surname>Olsufyeva</surname>
                            <given-names>E.N.</given-names>
                        </name>
                    </person-group>
                    <article-title>New conjugates of polyene macrolide amphotericin B with benzoxaboroles: Synthesis and properties.</article-title>
                    <source>J. Antibiot. (Tokyo)</source>
                    <year>2016</year>
                    <volume>69</volume>
                    <issue>7</issue>
                    <fpage>549</fpage>
                    <lpage>560</lpage>
                    <pub-id pub-id-type="doi">10.1038/ja.2016.34</pub-id> <pub-id pub-id-type="pmid"> 27005557</pub-id>
                </element-citation>
            </ref>
            <ref id="r40">
                <label>40</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Skwarecki</surname>
                            <given-names>A.S.</given-names>
                        </name>
                        <name>
                            <surname>Skarbek</surname>
                            <given-names>K.</given-names>
                        </name>
                        <name>
                            <surname>Martynow</surname>
                            <given-names>D.</given-names>
                        </name>
                        <name>
                            <surname>Serocki</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Byli&#x0144;ska</surname>
                            <given-names>I.</given-names>
                        </name>
                        <name>
                            <surname>Milewska</surname>
                            <given-names>M.J.</given-names>
                        </name>
                        <name>
                            <surname>Milewski</surname>
                            <given-names>S.</given-names>
                        </name>
                    </person-group>
                    <article-title>Molecular umbrellas modulate the selective toxicity of polyene macrolide antifungals.</article-title>
                    <source>Bioconjug. Chem.</source>
                    <year>2018</year>
                    <volume>29</volume>
                    <issue>4</issue>
                    <fpage>1454</fpage>
                    <lpage>1465</lpage>
                    <pub-id pub-id-type="doi">10.1021/acs.bioconjchem.8b00136</pub-id> <pub-id pub-id-type="pmid"> 29485855</pub-id>
                </element-citation>
            </ref>
            <ref id="r41">
                <label>41</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Day</surname>
                            <given-names>T.P.</given-names>
                        </name>
                        <name>
                            <surname>Sil</surname>
                            <given-names>D.</given-names>
                        </name>
                        <name>
                            <surname>Shukla</surname>
                            <given-names>N.M.</given-names>
                        </name>
                        <name>
                            <surname>Anbanandam</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Day</surname>
                            <given-names>V.W.</given-names>
                        </name>
                        <name>
                            <surname>David</surname>
                            <given-names>S.A.</given-names>
                        </name>
                    </person-group>
                    <article-title>Imbuing aqueous solubility to amphotericin B and nystatin with a vitamin.</article-title>
                    <source>Mol. Pharm.</source>
                    <year>2011</year>
                    <volume>8</volume>
                    <issue>1</issue>
                    <fpage>297</fpage>
                    <lpage>301</lpage>
                    <pub-id pub-id-type="doi">10.1021/mp100363f</pub-id> <pub-id pub-id-type="pmid"> 21141891</pub-id>
                </element-citation>
            </ref>
            <ref id="r42">
                <label>42</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Palacios</surname>
                            <given-names>D.S.</given-names>
                        </name>
                        <name>
                            <surname>Anderson</surname>
                            <given-names>T.M.</given-names>
                        </name>
                        <name>
                            <surname>Burke</surname>
                            <given-names>M.D.</given-names>
                        </name>
                    </person-group>
                    <article-title>A post-PKS oxidation of the amphotericin B skeleton predicted to be critical for channel formation is not required for potent antifungal activity.</article-title>
                    <source>J. Am. Chem. Soc.</source>
                    <year>2007</year>
                    <volume>129</volume>
                    <issue>45</issue>
                    <fpage>13804</fpage>
                    <lpage>13805</lpage>
                    <pub-id pub-id-type="doi">10.1021/ja075739o</pub-id> <pub-id pub-id-type="pmid"> 17956100</pub-id>
                </element-citation>
            </ref>
            <ref id="r43">
                <label>43</label>
                <element-citation publication-type="other">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Burke</surname>
                            <given-names>M.</given-names>
                        </name>
                    </person-group>
                    <article-title>Electronic tuning of site selectivity</article-title>
                    <patent>WO 2014059436 Al</patent>
                </element-citation>
            </ref>
            <ref id="r44">
                <label>44</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Davis</surname>
                            <given-names>S.A.</given-names>
                        </name>
                        <name>
                            <surname>Della Ripa</surname>
                            <given-names>L.A.</given-names>
                        </name>
                        <name>
                            <surname>Hu</surname>
                            <given-names>L.</given-names>
                        </name>
                        <name>
                            <surname>Cioffi</surname>
                            <given-names>A.G.</given-names>
                        </name>
                        <name>
                            <surname>Pogorelov</surname>
                            <given-names>T.V.</given-names>
                        </name>
                        <name>
                            <surname>Rienstra</surname>
                            <given-names>C.M.</given-names>
                        </name>
                        <name>
                            <surname>Burke</surname>
                            <given-names>M.D.</given-names>
                        </name>
                    </person-group>
                    <article-title>C3-OH of Amphotericin B plays an important role in ion conductance.</article-title>
                    <source>J. Am. Chem. Soc.</source>
                    <year>2015</year>
                    <volume>137</volume>
                    <issue>48</issue>
                    <fpage>15102</fpage>
                    <lpage>15104</lpage>
                    <pub-id pub-id-type="doi">10.1021/jacs.5b05766</pub-id> <pub-id pub-id-type="pmid"> 26580003</pub-id>
                </element-citation>
            </ref>
            <ref id="r45">
                <label>45</label>
                <element-citation publication-type="book">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Davis</surname>
                            <given-names>S.A.</given-names>
                        </name>
                    </person-group>
                    <source>Less toxic yet still resistance evasive amphotericins and atomistic probing of the amphotericin B ion channel.</source>
                    <publisher-name>University of Illinois</publisher-name>
                    <year>2015</year>
                </element-citation>
            </ref>
            <ref id="r46">
                <label>46</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Yamamoto</surname>
                            <given-names>T.</given-names>
                        </name>
                        <name>
                            <surname>Umegawa</surname>
                            <given-names>Y.</given-names>
                        </name>
                        <name>
                            <surname>Yamagami</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Suzuki</surname>
                            <given-names>T.</given-names>
                        </name>
                        <name>
                            <surname>Tsuchikawa</surname>
                            <given-names>H.</given-names>
                        </name>
                        <name>
                            <surname>Hanashima</surname>
                            <given-names>S.</given-names>
                        </name>
                        <name>
                            <surname>Matsumori</surname>
                            <given-names>N.</given-names>
                        </name>
                        <name>
                            <surname>Murata</surname>
                            <given-names>M.</given-names>
                        </name>
                    </person-group>
                    <article-title>The perpendicular orientation of amphotericin B methyl ester in hydrated lipid bilayers supports the barrel-stave model.</article-title>
                    <source>Biochemistry</source>
                    <year>2019</year>
                    <volume>58</volume>
                    <issue>17</issue>
                    <fpage>2282</fpage>
                    <lpage>2291</lpage>
                    <pub-id pub-id-type="doi">10.1021/acs.biochem.9b00180</pub-id> <pub-id pub-id-type="pmid"> 30973009</pub-id>
                </element-citation>
            </ref>
            <ref id="r47">
                <label>47</label>
                <element-citation publication-type="other">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Schaffner Carl</surname>
                            <given-names>P.</given-names>
                        </name>
                        <name>
                            <surname>Witold</surname>
                            <given-names>M.</given-names>
                        </name>
                    </person-group>
                    <article-title>Derivatives of polyene macrolide antibiotics.</article-title>
                    <patent>United States Patent 3,945,993</patent>
                    <year>1976</year>
                </element-citation>
            </ref>
            <ref id="r48">
                <label>48</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Paquet</surname>
                            <given-names>V.</given-names>
                        </name>
                        <name>
                            <surname>Carreira</surname>
                            <given-names>E.M.</given-names>
                        </name>
                    </person-group>
                    <article-title>Significant improvement of antifungal activity of polyene macrolides by bisalkylation of the mycosamine.</article-title>
                    <source>Org. Lett.</source>
                    <year>2006</year>
                    <volume>8</volume>
                    <issue>9</issue>
                    <fpage>1807</fpage>
                    <lpage>1809</lpage>
                    <pub-id pub-id-type="doi">10.1021/ol060353o</pub-id> <pub-id pub-id-type="pmid"> 16623556</pub-id>
                </element-citation>
            </ref>
            <ref id="r49">
                <label>49</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Zumbuehl</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Stano</surname>
                            <given-names>P.</given-names>
                        </name>
                        <name>
                            <surname>Sohrmann</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Peter</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Walde</surname>
                            <given-names>P.</given-names>
                        </name>
                        <name>
                            <surname>Carreira</surname>
                            <given-names>E.M.</given-names>
                        </name>
                    </person-group>
                    <article-title>A novel strategy for bioconjugation: Synthesis and preliminary evaluation with amphotericin B.</article-title>
                    <source>Org. Biomol. Chem.</source>
                    <year>2007</year>
                    <volume>5</volume>
                    <issue>9</issue>
                    <fpage>1339</fpage>
                    <lpage>1342</lpage>
                    <pub-id pub-id-type="doi">10.1039/b701953j</pub-id> <pub-id pub-id-type="pmid"> 17464400</pub-id>
                </element-citation>
            </ref>
            <ref id="r50">
                <label>50</label>
                <element-citation publication-type="other">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Judice</surname>
                            <given-names>J.</given-names>
                        </name>
                    </person-group>
                    <article-title>Compositions and methods for the treatment of presbyopia</article-title>
                    <patent>WO 2015164289 A1 2015</patent>
                    
                </element-citation>
            </ref>
            <ref id="r51">
                <label>51</label>
                <element-citation publication-type="other">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Burke</surname>
                            <given-names>M.D.</given-names>
                        </name>
                        <name>
                            <surname>Thottumkara</surname>
                            <given-names>A.</given-names>
                        </name>
                    </person-group>
                    <article-title>Derivatives of amphotericin B</article-title>
                    <patent>WO 2016168568 Al</patent>
                    <year>2016</year>
                </element-citation>
            </ref>
            <ref id="r52">
                <label>52</label>
                <element-citation publication-type="other">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Burke</surname>
                            <given-names>M.D.</given-names>
                        </name>
                    </person-group>
                    <article-title>Antifungal polyene macrolide derivatives with reduced mammalian toxicity</article-title>
                    <patent>WO 2016014779 Al (2016)</patent>
                    
                </element-citation>
            </ref>
            <ref id="r53">
                <label>53</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Chugunova</surname>
                            <given-names>E.A.</given-names>
                        </name>
                        <name>
                            <surname>Mukhamatdinova</surname>
                            <given-names>R.E.</given-names>
                        </name>
                        <name>
                            <surname>Sazykina</surname>
                            <given-names>M.A.</given-names>
                        </name>
                        <name>
                            <surname>Sazykin</surname>
                            <given-names>I.S.</given-names>
                        </name>
                        <name>
                            <surname>Khammami</surname>
                            <given-names>M.I.</given-names>
                        </name>
                        <name>
                            <surname>Akylbekov</surname>
                            <given-names>N.I.</given-names>
                        </name>
                        <name>
                            <surname>Burilov</surname>
                            <given-names>A.R.</given-names>
                        </name>
                        <name>
                            <surname>Kulik</surname>
                            <given-names>N.V.</given-names>
                        </name>
                        <name>
                            <surname>Zobov</surname>
                            <given-names>V.V.</given-names>
                        </name>
                    </person-group>
                    <article-title>Synthesis and biological activity of new hybrids compounds derived from benzofuroxanes and polyene antibiotics.</article-title>
                    <source>Russ. J. Gen. Chem.</source>
                    <year>2016</year>
                    <volume>86</volume>
                    <issue>5</issue>
                    <fpage>1037</fpage>
                    <lpage>1040</lpage>
                    <pub-id pub-id-type="doi">10.1134/S1070363216050091</pub-id>
                </element-citation>
            </ref>
            <ref id="r54">
                <label>54</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Flores-Romero</surname>
                            <given-names>J.D.</given-names>
                        </name>
                        <name>
                            <surname>Rodr&#x00ED;guez-Lozada</surname>
                            <given-names>J.</given-names>
                        </name>
                        <name>
                            <surname>L&#x00F3;pez-Ortiz</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Maga&#x00F1;a</surname>
                            <given-names>R.</given-names>
                        </name>
                        <name>
                            <surname>Ortega-Blake</surname>
                            <given-names>I.</given-names>
                        </name>
                        <name>
                            <surname>Regla</surname>
                            <given-names>I.</given-names>
                        </name>
                        <name>
                            <surname>Fern&#x00E1;ndez-Zertuche</surname>
                            <given-names>M.</given-names>
                        </name>
                    </person-group>
                    <article-title>Multigram scale synthesis of a21, a new antibiotic equally effective and less toxic than amphotericin B.</article-title>
                    <source>Org. Process Res. Dev.</source>
                    <year>2016</year>
                    <volume>20</volume>
                    <issue>8</issue>
                    <fpage>1529</fpage>
                    <lpage>1532</lpage>
                    <pub-id pub-id-type="doi">10.1021/acs.oprd.6b00211</pub-id>
                </element-citation>
            </ref>
            <ref id="r55">
                <label>55</label>
                <element-citation publication-type="other">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Pinchman</surname>
                            <given-names>J.R.</given-names>
                        </name>
                        <name>
                            <surname>Bunker</surname>
                            <given-names>K.D.</given-names>
                        </name>
                        <name>
                            <surname>Huang</surname>
                            <given-names>P.Q.</given-names>
                        </name>
                        <name>
                            <surname>Slee</surname>
                            <given-names>D.H.</given-names>
                        </name>
                        <name>
                            <surname>Hopkins</surname>
                            <given-names>C.D.</given-names>
                        </name>
                    </person-group>
                    <article-title>Antifungal compounds and methods.</article-title>
                    <patent>WO2017/100171Al</patent>
                    <year>2017</year>
                </element-citation>
            </ref>
            <ref id="r56">
                <label>56</label>
                <element-citation publication-type="other">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Bunker</surname>
                            <given-names>K.D.</given-names>
                        </name>
                        <name>
                            <surname>Pinchman</surname>
                            <given-names>J.R.</given-names>
                        </name>
                    </person-group>
                    <article-title>Antifungal compounds &amp; methods</article-title>
                    <patent>WO 2018106571 Al (2018).</patent>
                    
                </element-citation>
            </ref>
            <ref id="r57">
                <label>57</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Nicolaou</surname>
                            <given-names>K.C.</given-names>
                        </name>
                        <name>
                            <surname>Chakraborty</surname>
                            <given-names>T.K.</given-names>
                        </name>
                        <name>
                            <surname>Ogawa</surname>
                            <given-names>Y.</given-names>
                        </name>
                        <name>
                            <surname>Daines</surname>
                            <given-names>R.A.</given-names>
                        </name>
                        <name>
                            <surname>Simpkins</surname>
                            <given-names>N.S.</given-names>
                        </name>
                        <name>
                            <surname>Furst</surname>
                            <given-names>G.T.</given-names>
                        </name>
                    </person-group>
                    <article-title>Chemistry of amphotericin b. degradation studies and preparation of amphoteronolide B.</article-title>
                    <source>J. Am. Chem. Soc.</source>
                    <year>1988</year>
                    <volume>110</volume>
                    <issue>14</issue>
                    <fpage>4660</fpage>
                    <lpage>4672</lpage>
                    <pub-id pub-id-type="doi">10.1021/ja00222a027</pub-id>
                </element-citation>
            </ref>
            <ref id="r58">
                <label>58</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Elgart</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Farber</surname>
                            <given-names>S.</given-names>
                        </name>
                        <name>
                            <surname>Domb</surname>
                            <given-names>A.J.</given-names>
                        </name>
                        <name>
                            <surname>Polacheck</surname>
                            <given-names>I.</given-names>
                        </name>
                        <name>
                            <surname>Hoffman</surname>
                            <given-names>A.</given-names>
                        </name>
                    </person-group>
                    <article-title>Polysaccharide pharmacokinetics: Amphotericin B arabinogalactan conjugate-a drug delivery system or a new pharmaceutical entity?</article-title>
                    <source>Biomacromolecules</source>
                    <year>2010</year>
                    <volume>11</volume>
                    <issue>8</issue>
                    <fpage>1972</fpage>
                    <lpage>1977</lpage>
                    <pub-id pub-id-type="doi">10.1021/bm100298r</pub-id> <pub-id pub-id-type="pmid"> 20690709</pub-id>
                </element-citation>
            </ref>
            <ref id="r59">
                <label>59</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Mohamed-Ahmed</surname>
                            <given-names>A.H.A.</given-names>
                        </name>
                        <name>
                            <surname>Les</surname>
                            <given-names>K.A.</given-names>
                        </name>
                        <name>
                            <surname>Seifert</surname>
                            <given-names>K.</given-names>
                        </name>
                        <name>
                            <surname>Croft</surname>
                            <given-names>S.L.</given-names>
                        </name>
                        <name>
                            <surname>Brocchini</surname>
                            <given-names>S.</given-names>
                        </name>
                    </person-group>
                    <article-title>Noncovalent complexation of amphotericin-B with Poly(&#x03B1;-glutamic acid).</article-title>
                    <source>Mol. Pharm.</source>
                    <year>2013</year>
                    <volume>10</volume>
                    <issue>3</issue>
                    <fpage>940</fpage>
                    <lpage>950</lpage>
                    <pub-id pub-id-type="doi">10.1021/mp300339p</pub-id> <pub-id pub-id-type="pmid"> 23234235</pub-id>
                </element-citation>
            </ref>
            <ref id="r60">
                <label>60</label>
                <element-citation publication-type="other">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Borowski</surname>
                            <given-names>E.</given-names>
                        </name>
                        <name>
                            <surname>Salewska</surname>
                            <given-names>N.</given-names>
                        </name>
                        <name>
                            <surname>Boros-Majewska</surname>
                            <given-names>J.</given-names>
                        </name>
                        <name>
                            <surname>Milewska</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Wysocka</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Milewski</surname>
                            <given-names>S.</given-names>
                        </name>
                        <name>
                            <surname>&#x0141;&#x0105;cka</surname>
                            <given-names>I.</given-names>
                        </name>
                        <name>
                            <surname>Sabisz</surname>
                            <given-names>M.</given-names>
                        </name>
                    </person-group>
                    <article-title>IV-substituted second generation derivaties of antifungal antibiotic amphotericin B and methods of thier preparation and application.</article-title>
                    <patent>WO2013/186384Al</patent>
                    <year>2013</year>
                </element-citation>
            </ref>
            <ref id="r61">
                <label>61</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Thanki</surname>
                            <given-names>K.</given-names>
                        </name>
                        <name>
                            <surname>Date</surname>
                            <given-names>T.</given-names>
                        </name>
                        <name>
                            <surname>Jain</surname>
                            <given-names>S.</given-names>
                        </name>
                    </person-group>
                    <article-title>Improved oral bioavailability and gastrointestinal stability of amphotericin b through fatty acid conjugation approach.</article-title>
                    <source>Mol. Pharm.</source>
                    <year>2019</year>
                    <volume>16</volume>
                    <issue>11</issue>
                    <fpage>4519</fpage>
                    <lpage>4529</lpage>
                    <pub-id pub-id-type="doi">10.1021/acs.molpharmaceut.9b00662</pub-id> <pub-id pub-id-type="pmid"> 31509418</pub-id>
                </element-citation>
            </ref>
            <ref id="r62">
                <label>62</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Zhang</surname>
                            <given-names>J.</given-names>
                        </name>
                        <name>
                            <surname>Ma</surname>
                            <given-names>J.</given-names>
                        </name>
                        <name>
                            <surname>Dong</surname>
                            <given-names>Y.</given-names>
                        </name>
                        <name>
                            <surname>Zhao</surname>
                            <given-names>W.</given-names>
                        </name>
                        <name>
                            <surname>Feng</surname>
                            <given-names>J.</given-names>
                        </name>
                    </person-group>
                    <article-title>Synthesis and characterization of NH2-(AEEA)n-amphotericin B derivatives.</article-title>
                    <source>J. Antibiot. (Tokyo)</source>
                    <year>2019</year>
                    <volume>72</volume>
                    <issue>4</issue>
                    <fpage>210</fpage>
                    <lpage>217</lpage>
                    <pub-id pub-id-type="doi">10.1038/s41429-018-0138-8</pub-id> <pub-id pub-id-type="pmid"> 30635615</pub-id>
                </element-citation>
            </ref>
            <ref id="r63">
                <label>63</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Tevyashova</surname>
                            <given-names>A.N.</given-names>
                        </name>
                        <name>
                            <surname>Bychkova</surname>
                            <given-names>E.N.</given-names>
                        </name>
                        <name>
                            <surname>Solovieva</surname>
                            <given-names>S.E.</given-names>
                        </name>
                        <name>
                            <surname>Zatonsky</surname>
                            <given-names>G.V.</given-names>
                        </name>
                        <name>
                            <surname>Grammatikova</surname>
                            <given-names>N.E.</given-names>
                        </name>
                        <name>
                            <surname>Isakova</surname>
                            <given-names>E.B.</given-names>
                        </name>
                        <name>
                            <surname>Mirchink</surname>
                            <given-names>E.P.</given-names>
                        </name>
                        <name>
                            <surname>Treshchalin</surname>
                            <given-names>I.D.</given-names>
                        </name>
                        <name>
                            <surname>Pereverzeva</surname>
                            <given-names>E.R.</given-names>
                        </name>
                        <name>
                            <surname>Bykov</surname>
                            <given-names>E.E.</given-names>
                        </name>
                        <name>
                            <surname>Efimova</surname>
                            <given-names>S.S.</given-names>
                        </name>
                        <name>
                            <surname>Ostroumova</surname>
                            <given-names>O.S.</given-names>
                        </name>
                        <name>
                            <surname>Shchekotikhin</surname>
                            <given-names>A.E.</given-names>
                        </name>
                    </person-group>
                    <article-title>Discovery of amphamide, a drug candidate for the second generation of polyene antibiotics.</article-title>
                    <source>ACS Infect. Dis.</source>
                    <year>2020</year>
                    <volume>6</volume>
                    <issue>8</issue>
                    <fpage>2029</fpage>
                    <lpage>2044</lpage>
                    <pub-id pub-id-type="doi">10.1021/acsinfecdis.0c00068</pub-id> <pub-id pub-id-type="pmid"> 32598131</pub-id>
                </element-citation>
            </ref>
            <ref id="r64">
                <label>64</label>
                <element-citation publication-type="other">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Carriera</surname>
                            <given-names>E.</given-names>
                        </name>
                    </person-group>
                    <article-title>Amphotericin derivatives</article-title>
                    <patent>WO 2007096137 Al (2007)</patent>
                    <year>2007</year>
                </element-citation>
            </ref>
            <ref id="r65">
                <label>65</label>
                <element-citation publication-type="other">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Burke</surname>
                            <given-names>M.D.</given-names>
                        </name>
                        <name>
                            <surname>Davis</surname>
                            <given-names>S.</given-names>
                        </name>
                        <name>
                            <surname>Uno</surname>
                            <given-names>B.E.</given-names>
                        </name>
                        <name>
                            <surname>Struble</surname>
                            <given-names>J.</given-names>
                        </name>
                        <name>
                            <surname>Dailey</surname>
                            <given-names>I.</given-names>
                        </name>
                        <name>
                            <surname>Gray</surname>
                            <given-names>K.C.</given-names>
                        </name>
                        <name>
                            <surname>Knapp</surname>
                            <given-names>D.M.</given-names>
                        </name>
                        <name>
                            <surname>Wang</surname>
                            <given-names>P.</given-names>
                        </name>
                        <name>
                            <surname>Palyam</surname>
                            <given-names>N.</given-names>
                        </name>
                    </person-group>
                    <article-title>Amphotericin B derivatives with improved therapeutic index</article-title>
                    <patent>WO 2015054148 A1 (2015).</patent>
                    
                </element-citation>
            </ref>
            <ref id="r66">
                <label>66</label>
                <element-citation publication-type="other">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Burke</surname>
                            <given-names>M.D.</given-names>
                        </name>
                    </person-group>
                    <article-title>Concise synthesis of urea derivatives of amphotericin
	B</article-title>
                    <patent>WO 2016112260 (2016)</patent>
                    <year>2016</year>
                </element-citation>
            </ref>
            <ref id="r67">
                <label>67</label>
                <element-citation publication-type="other">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Tucker</surname>
                            <given-names>M.D.B.D.</given-names>
                        </name>
                    </person-group>
                    <article-title>Urea derivatives of AmB derived from secondary amines</article-title>
                    <patent>WO 2016/112243 Al (2016)</patent>
                    <year>2016</year>
                </element-citation>
            </ref>
            <ref id="r68">
                <label>68</label>
                <element-citation publication-type="other">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Burke</surname>
                            <given-names>M.D.</given-names>
                        </name>
                    </person-group>

                    <patent>WO2016061437.</patent>
                </element-citation>
            </ref>
            <ref id="r69">
                <label>69</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Davis</surname>
                            <given-names>S.A.</given-names>
                        </name>
                        <name>
                            <surname>Vincent</surname>
                            <given-names>B.M.</given-names>
                        </name>
                        <name>
                            <surname>Endo</surname>
                            <given-names>M.M.</given-names>
                        </name>
                        <name>
                            <surname>Whitesell</surname>
                            <given-names>L.</given-names>
                        </name>
                        <name>
                            <surname>Marchillo</surname>
                            <given-names>K.</given-names>
                        </name>
                        <name>
                            <surname>Andes</surname>
                            <given-names>D.R.</given-names>
                        </name>
                        <name>
                            <surname>Lindquist</surname>
                            <given-names>S.</given-names>
                        </name>
                        <name>
                            <surname>Burke</surname>
                            <given-names>M.D.</given-names>
                        </name>
                    </person-group>
                    <article-title>Nontoxic antimicrobials that evade drug resistance.</article-title>
                    <source>Nat. Chem. Biol.</source>
                    <year>2015</year>
                    <volume>11</volume>
                    <issue>7</issue>
                    <fpage>481</fpage>
                    <lpage>487</lpage>
                    <pub-id pub-id-type="doi">10.1038/nchembio.1821</pub-id> <pub-id pub-id-type="pmid"> 26030729</pub-id>
                </element-citation>
            </ref>
            <ref id="r70">
                <label>70</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Conover</surname>
                            <given-names>C.D.</given-names>
                        </name>
                        <name>
                            <surname>Zhao</surname>
                            <given-names>H.</given-names>
                        </name>
                        <name>
                            <surname>Longley</surname>
                            <given-names>C.B.</given-names>
                        </name>
                        <name>
                            <surname>Shum</surname>
                            <given-names>K.L.</given-names>
                        </name>
                        <name>
                            <surname>Greenwald</surname>
                            <given-names>R.B.</given-names>
                        </name>
                    </person-group>
                    <article-title>Utility of poly(ethylene glycol) conjugation to create prodrugs of amphotericin B.</article-title>
                    <source>Bioconjug. Chem.</source>
                    <year>2003</year>
                    <volume>14</volume>
                    <issue>3</issue>
                    <fpage>661</fpage>
                    <lpage>666</lpage>
                    <pub-id pub-id-type="doi">10.1021/bc0256594</pub-id> <pub-id pub-id-type="pmid"> 12757392</pub-id>
                </element-citation>
            </ref>
            <ref id="r71">
                <label>71</label>
                <element-citation publication-type="other">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Borders</surname>
                            <given-names>D.B.</given-names>
                        </name>
                    </person-group>
                    <article-title>Methods for preparing salts of polyene macrolide
	esters</article-title>
                    <patent>US2003/0040610Al</patent>
                    <year>2003</year>
                </element-citation>
            </ref>
            <ref id="r72">
                <label>72</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Sedl&#x00E1;k</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Drabina</surname>
                            <given-names>P.</given-names>
                        </name>
                        <name>
                            <surname>B&#x00ED;lkov&#x00E1;</surname>
                            <given-names>E.</given-names>
                        </name>
                        <name>
                            <surname>Sim&#x016F;nek</surname>
                            <given-names>P.</given-names>
                        </name>
                        <name>
                            <surname>Buchta</surname>
                            <given-names>V.</given-names>
                        </name>
                    </person-group>
                    <article-title>New targeting system for antimycotic drugs: &#x03B2;-glucosidase sensitive amphotericin B-star poly(ethylene glycol) conjugate.</article-title>
                    <source>Bioorg. Med. Chem. Lett.</source>
                    <year>2008</year>
                    <volume>18</volume>
                    <issue>9</issue>
                    <fpage>2952</fpage>
                    <lpage>2956</lpage>
                    <pub-id pub-id-type="doi">10.1016/j.bmcl.2008.03.065</pub-id> <pub-id pub-id-type="pmid"> 18396401</pub-id>
                </element-citation>
            </ref>
            <ref id="r73">
                <label>73</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Liu</surname>
                            <given-names>S.Y.</given-names>
                        </name>
                        <name>
                            <surname>Liu</surname>
                            <given-names>H.</given-names>
                        </name>
                        <name>
                            <surname>Shen</surname>
                            <given-names>Z.Q.</given-names>
                        </name>
                        <name>
                            <surname>Huang</surname>
                            <given-names>W.Y.</given-names>
                        </name>
                        <name>
                            <surname>Zhong</surname>
                            <given-names>A.G.</given-names>
                        </name>
                        <name>
                            <surname>Wen</surname>
                            <given-names>H.R.</given-names>
                        </name>
                    </person-group>
                    <article-title>Atom- and step-economic synthesis of &#x03C0;-conjugated large oligomers via CH activated oligomerization.</article-title>
                    <source>Dyes Pigments</source>
                    <year>2019</year>
                    <volume>162</volume>
                    <fpage>640</fpage>
                    <lpage>646</lpage>
                    <pub-id pub-id-type="doi">10.1016/j.dyepig.2018.10.075</pub-id>
                </element-citation>
            </ref>
            <ref id="r74">
                <label>74</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Liu</surname>
                            <given-names>S.Y.</given-names>
                        </name>
                        <name>
                            <surname>Liu</surname>
                            <given-names>W.Q.</given-names>
                        </name>
                        <name>
                            <surname>Yuan</surname>
                            <given-names>C.X.</given-names>
                        </name>
                        <name>
                            <surname>Zhong</surname>
                            <given-names>A.G.</given-names>
                        </name>
                        <name>
                            <surname>Han</surname>
                            <given-names>D.</given-names>
                        </name>
                        <name>
                            <surname>Wang</surname>
                            <given-names>B.</given-names>
                        </name>
                        <name>
                            <surname>Shah</surname>
                            <given-names>M.N.</given-names>
                        </name>
                        <name>
                            <surname>Shi</surname>
                            <given-names>M.M.</given-names>
                        </name>
                        <name>
                            <surname>Chen</surname>
                            <given-names>H.</given-names>
                        </name>
                    </person-group>
                    <article-title>Diketopyrrolopyrrole-based oligomers accessed via sequential C[Formula Presented]H activated coupling for fullerene-free organic photovoltaics.</article-title>
                    <source>Dyes Pigments</source>
                    <year>2016</year>
                    <volume>134</volume>
                    <fpage>139</fpage>
                    <lpage>147</lpage>
                    <pub-id pub-id-type="doi">10.1016/j.dyepig.2016.07.007</pub-id>
                </element-citation>
            </ref>
            <ref id="r75">
                <label>75</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Ai-Guo</surname>
                            <given-names>Z.</given-names>
                        </name>
                    </person-group>
                    <article-title>Dissecting the nature of halogen bonding interactions from energy decomposition and wavefunction analysis.</article-title>
                    <source>Monatsh. Chem.</source>
                    <year>2017</year>
                    <volume>148</volume>
                    <issue>7</issue>
                    <fpage>1259</fpage>
                    <lpage>1267</lpage>
                    <pub-id pub-id-type="doi">10.1007/s00706-017-1937-5</pub-id>
                </element-citation>
            </ref>
            <ref id="r76">
                <label>76</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Villamil</surname>
                            <given-names>J.C.</given-names>
                        </name>
                        <name>
                            <surname>Parra-Giraldo</surname>
                            <given-names>C.M.</given-names>
                        </name>
                        <name>
                            <surname>P&#x00E9;rez</surname>
                            <given-names>L.D.</given-names>
                        </name>
                    </person-group>
                    <article-title>Enhancing the performance of PEG-b-PCL copolymers as precursors of micellar vehicles for amphotericin B through its conjugation with cholesterol.</article-title>
                    <source>Colloids Surf. A Physicochem. Eng. Asp.</source>
                    <year>2019</year>
                    <volume>572</volume>
                    <issue>March</issue>
                    <fpage>79</fpage>
                    <lpage>87</lpage>
                    <pub-id pub-id-type="doi">10.1016/j.colsurfa.2019.03.086</pub-id>
                </element-citation>
            </ref>
            <ref id="r77">
                <label>77</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Chaudhari</surname>
                            <given-names>M.B.</given-names>
                        </name>
                        <name>
                            <surname>Desai</surname>
                            <given-names>P.P.</given-names>
                        </name>
                        <name>
                            <surname>Patel</surname>
                            <given-names>P.A.</given-names>
                        </name>
                        <name>
                            <surname>Patravale</surname>
                            <given-names>V.B.</given-names>
                        </name>
                    </person-group>
                    <article-title>Solid lipid nanoparticles of amphotericin B (AmbiOnp): In vitro and in vivo assessment towards safe and effective oral treatment module.</article-title>
                    <source>Drug Deliv. Transl. Res.</source>
                    <year>2016</year>
                    <volume>6</volume>
                    <issue>4</issue>
                    <fpage>354</fpage>
                    <lpage>364</lpage>
                    <pub-id pub-id-type="doi">10.1007/s13346-015-0267-6</pub-id> <pub-id pub-id-type="pmid"> 26712123</pub-id>
                </element-citation>
            </ref>
            <ref id="r78">
                <label>78</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Butani</surname>
                            <given-names>D.</given-names>
                        </name>
                        <name>
                            <surname>Yewale</surname>
                            <given-names>C.</given-names>
                        </name>
                        <name>
                            <surname>Misra</surname>
                            <given-names>A.</given-names>
                        </name>
                    </person-group>
                    <article-title>Topical Amphotericin B solid lipid nanoparticles: Design and development.</article-title>
                    <source>Colloids Surf. B Biointerfaces</source>
                    <year>2016</year>
                    <volume>139</volume>
                    <fpage>17</fpage>
                    <lpage>24</lpage>
                    <pub-id pub-id-type="doi">10.1016/j.colsurfb.2015.07.032</pub-id> <pub-id pub-id-type="pmid"> 26700229</pub-id>
                </element-citation>
            </ref>
            <ref id="r79">
                <label>79</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Kumar</surname>
                            <given-names>R.</given-names>
                        </name>
                        <name>
                            <surname>Sahoo</surname>
                            <given-names>G.C.</given-names>
                        </name>
                        <name>
                            <surname>Pandey</surname>
                            <given-names>K.</given-names>
                        </name>
                        <name>
                            <surname>Das</surname>
                            <given-names>V.</given-names>
                        </name>
                        <name>
                            <surname>Das</surname>
                            <given-names>P.</given-names>
                        </name>
                    </person-group>
                    <article-title>Study the effects of PLGA-PEG encapsulated amphotericin B nanoparticle drug delivery system against Leishmania donovani.</article-title>
                    <source>Drug Deliv.</source>
                    <year>2015</year>
                    <volume>22</volume>
                    <issue>3</issue>
                    <fpage>383</fpage>
                    <lpage>388</lpage>
                    <pub-id pub-id-type="doi">10.3109/10717544.2014.891271</pub-id> <pub-id pub-id-type="pmid"> 24601828</pub-id>
                </element-citation>
            </ref>
            <ref id="r80">
                <label>80</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Radwan</surname>
                            <given-names>M.A.</given-names>
                        </name>
                        <name>
                            <surname>AlQuadeib</surname>
                            <given-names>B.T.</given-names>
                        </name>
                        <name>
                            <surname>&#x0160;iller</surname>
                            <given-names>L.</given-names>
                        </name>
                        <name>
                            <surname>Wright</surname>
                            <given-names>M.C.</given-names>
                        </name>
                        <name>
                            <surname>Horrocks</surname>
                            <given-names>B.</given-names>
                        </name>
                    </person-group>
                    <article-title>Oral administration of amphotericin B nanoparticles: Antifungal activity, bioavailability and toxicity in rats.</article-title>
                    <source>Drug Deliv.</source>
                    <year>2017</year>
                    <volume>24</volume>
                    <issue>1</issue>
                    <fpage>40</fpage>
                    <lpage>50</lpage>
                    <pub-id pub-id-type="doi">10.1080/10717544.2016.1228715</pub-id> <pub-id pub-id-type="pmid"> 28155565</pub-id>
                </element-citation>
            </ref>
            <ref id="r81">
                <label>81</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Al-Quadeib</surname>
                            <given-names>B.T.</given-names>
                        </name>
                        <name>
                            <surname>Radwan</surname>
                            <given-names>M.A.</given-names>
                        </name>
                        <name>
                            <surname>Siller</surname>
                            <given-names>L.</given-names>
                        </name>
                        <name>
                            <surname>Horrocks</surname>
                            <given-names>B.</given-names>
                        </name>
                        <name>
                            <surname>Wright</surname>
                            <given-names>M.C.</given-names>
                        </name>
                    </person-group>
                    <article-title>Stealth Amphotericin B nanoparticles for oral drug delivery: In vitro optimization.</article-title>
                    <source>Saudi Pharm. J.</source>
                    <year>2015</year>
                    <volume>23</volume>
                    <issue>3</issue>
                    <fpage>290</fpage>
                    <lpage>302</lpage>
                    <pub-id pub-id-type="doi">10.1016/j.jsps.2014.11.004</pub-id> <pub-id pub-id-type="pmid"> 26106277</pub-id>
                </element-citation>
            </ref>
            <ref id="r82">
                <label>82</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Tan</surname>
                            <given-names>L.</given-names>
                        </name>
                    </person-group>
                    <article-title>J.S.; Roberts, C.J.; Billa, N. Mucoadhesive chitosan-coated nanostructured lipid carriers for oral delivery of amphotericin B.</article-title>
                    <source>Pharm. Dev. Technol.</source>
                    <year>2019</year>
                    <volume>24</volume>
                    <issue>4</issue>
                    <fpage>504</fpage>
                    <lpage>512</lpage>
                    <pub-id pub-id-type="doi">10.1080/10837450.2018.1515225</pub-id> <pub-id pub-id-type="pmid"> 30132723</pub-id>
                </element-citation>
            </ref>
            <ref id="r83">
                <label>83</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Subramaniam</surname>
                            <given-names>B.</given-names>
                        </name>
                        <name>
                            <surname>Siddik</surname>
                            <given-names>Z.H.</given-names>
                        </name>
                        <name>
                            <surname>Nagoor</surname>
                            <given-names>N.H.</given-names>
                        </name>
                    </person-group>
                    <article-title>Optimization of nanostructured lipid carriers: Understanding the types, designs, and parameters in the process of formulations.</article-title>
                    <source>J. Nanopart. Res.</source>
                    <year>2020</year>
                    <volume>22</volume>
                    <issue>6</issue>
                    <pub-id pub-id-type="doi">10.1007/s11051-020-04848-0</pub-id>
                </element-citation>
            </ref>
            <ref id="r84">
                <label>84</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Chen</surname>
                            <given-names>Y.C.</given-names>
                        </name>
                        <name>
                            <surname>Su</surname>
                            <given-names>C.Y.</given-names>
                        </name>
                        <name>
                            <surname>Jhan</surname>
                            <given-names>H.J.</given-names>
                        </name>
                        <name>
                            <surname>Ho</surname>
                            <given-names>H.O.</given-names>
                        </name>
                        <name>
                            <surname>Sheu</surname>
                            <given-names>M.T.</given-names>
                        </name>
                    </person-group>
                    <article-title>Physical characterization and in vivo pharmacokinetic study of self-assembling amphotericin B-loaded lecithin-based mixed polymeric micelles.</article-title>
                    <source>Int. J. Nanomedicine</source>
                    <year>2015</year>
                    <volume>10</volume>
                    <fpage>7265</fpage>
                    <lpage>7274</lpage>
                    <pub-id pub-id-type="doi">10.2147/IJN.S95194</pub-id> <pub-id pub-id-type="pmid"> 26664117</pub-id>
                </element-citation>
            </ref>
            <ref id="r85">
                <label>85</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Wang</surname>
                            <given-names>Y.</given-names>
                        </name>
                        <name>
                            <surname>Ke</surname>
                            <given-names>X.</given-names>
                        </name>
                        <name>
                            <surname>Voo</surname>
                            <given-names>Z.X.</given-names>
                        </name>
                        <name>
                            <surname>Yap</surname>
                            <given-names>S.S.L.</given-names>
                        </name>
                        <name>
                            <surname>Yang</surname>
                            <given-names>C.</given-names>
                        </name>
                        <name>
                            <surname>Gao</surname>
                            <given-names>S.</given-names>
                        </name>
                        <name>
                            <surname>Liu</surname>
                            <given-names>S.</given-names>
                        </name>
                        <name>
                            <surname>Venkataraman</surname>
                            <given-names>S.</given-names>
                        </name>
                        <name>
                            <surname>Obuobi</surname>
                            <given-names>S.A.O.</given-names>
                        </name>
                        <name>
                            <surname>Khara</surname>
                            <given-names>J.S.</given-names>
                        </name>
                        <name>
                            <surname>Yang</surname>
                            <given-names>Y.Y.</given-names>
                        </name>
                        <name>
                            <surname>Ee</surname>
                            <given-names>P.L.R.</given-names>
                        </name>
                    </person-group>
                    <article-title>Biodegradable functional polycarbonate micelles for controlled release of amphotericin B.</article-title>
                    <source>Acta Biomater.</source>
                    <year>2016</year>
                    <volume>46</volume>
                    <fpage>211</fpage>
                    <lpage>220</lpage>
                    <pub-id pub-id-type="doi">10.1016/j.actbio.2016.09.036</pub-id> <pub-id pub-id-type="pmid"> 27686042</pub-id>
                </element-citation>
            </ref>
            <ref id="r86">
                <label>86</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Silva</surname>
                            <given-names>A.E.</given-names>
                        </name>
                        <name>
                            <surname>Barratt</surname>
                            <given-names>G.</given-names>
                        </name>
                        <name>
                            <surname>Ch&#x00E9;ron</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Egito</surname>
                            <given-names>E.S.T.</given-names>
                        </name>
                    </person-group>
                    <article-title>Development of oil-in-water microemulsions for the oral delivery of amphotericin B.</article-title>
                    <source>Int. J. Pharm.</source>
                    <year>2013</year>
                    <volume>454</volume>
                    <issue>2</issue>
                    <fpage>641</fpage>
                    <lpage>648</lpage>
                    <pub-id pub-id-type="doi">10.1016/j.ijpharm.2013.05.044</pub-id> <pub-id pub-id-type="pmid"> 23726904</pub-id>
                </element-citation>
            </ref>
            <ref id="r87">
                <label>87</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Richter</surname>
                            <given-names>A.R.</given-names>
                        </name>
                        <name>
                            <surname>Feitosa</surname>
                            <given-names>J.P.A.</given-names>
                        </name>
                        <name>
                            <surname>Paula</surname>
                            <given-names>H.C.B.</given-names>
                        </name>
                        <name>
                            <surname>Goycoolea</surname>
                            <given-names>F.M.</given-names>
                        </name>
                        <name>
                            <surname>de Paula</surname>
                            <given-names>R.C.M.</given-names>
                        </name>
                    </person-group>
                    <article-title>Pickering emulsion stabilized by cashew gum- poly-l-lactide copolymer nanoparticles: Synthesis, characterization and amphotericin B encapsulation.</article-title>
                    <source>Colloids Surf. B Biointerfaces</source>
                    <year>2018</year>
                    <volume>164</volume>
                    <fpage>201</fpage>
                    <lpage>209</lpage>
                    <pub-id pub-id-type="doi">10.1016/j.colsurfb.2018.01.023</pub-id> <pub-id pub-id-type="pmid"> 29413597</pub-id>
                </element-citation>
            </ref>
            <ref id="r88">
                <label>88</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Bhatia</surname>
                            <given-names>S.</given-names>
                        </name>
                        <name>
                            <surname>Kumar</surname>
                            <given-names>V.</given-names>
                        </name>
                        <name>
                            <surname>Sharma</surname>
                            <given-names>K.</given-names>
                        </name>
                        <name>
                            <surname>Nagpal</surname>
                            <given-names>K.</given-names>
                        </name>
                        <name>
                            <surname>Bera</surname>
                            <given-names>T.</given-names>
                        </name>
                    </person-group>
                    <article-title>Significance of algal polymer in designing amphotericin B nanoparticles.</article-title>
                    <source>ScientificWorldJournal</source>
                    <year>2014</year>
                    <volume>2014</volume>
                    <elocation-id>564573</elocation-id>
                    <pub-id pub-id-type="doi">10.1155/2014/564573</pub-id> <pub-id pub-id-type="pmid"> 25478596</pub-id>
                </element-citation>
            </ref>
            <ref id="r89">
                <label>89</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Mohamed</surname>
                            <given-names>H.A.</given-names>
                        </name>
                        <name>
                            <surname>Radwan</surname>
                            <given-names>R.R.</given-names>
                        </name>
                        <name>
                            <surname>Raafat</surname>
                            <given-names>A.I.</given-names>
                        </name>
                        <name>
                            <surname>Ali</surname>
                            <given-names>A.E.H.</given-names>
                        </name>
                    </person-group>
                    <article-title>Antifungal activity of oral (Tragacanth/acrylic acid) Amphotericin B carrier for systemic candidiasis: In vitro and in vivo study.</article-title>
                    <source>Drug Deliv. Transl. Res.</source>
                    <year>2018</year>
                    <volume>8</volume>
                    <issue>1</issue>
                    <fpage>191</fpage>
                    <lpage>203</lpage>
                    <pub-id pub-id-type="doi">10.1007/s13346-017-0452-x</pub-id> <pub-id pub-id-type="pmid"> 29280061</pub-id>
                </element-citation>
            </ref>
            <ref id="r90">
                <label>90</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Banshoya</surname>
                            <given-names>K.</given-names>
                        </name>
                        <name>
                            <surname>Kaneo</surname>
                            <given-names>Y.</given-names>
                        </name>
                        <name>
                            <surname>Tanaka</surname>
                            <given-names>T.</given-names>
                        </name>
                        <name>
                            <surname>Yamamoto</surname>
                            <given-names>S.</given-names>
                        </name>
                        <name>
                            <surname>Maeda</surname>
                            <given-names>H.</given-names>
                        </name>
                    </person-group>
                    <article-title>Synthesis and evaluation of styrene-maleic acid copolymer conjugated amphotericin B.</article-title>
                    <source>Int. J. Pharm.</source>
                    <year>2019</year>
                    <volume>572</volume>
                    <elocation-id>118719</elocation-id>
                    <pub-id pub-id-type="doi">10.1016/j.ijpharm.2019.118719</pub-id> <pub-id pub-id-type="pmid"> 31654700</pub-id>
                </element-citation>
            </ref>
            <ref id="r91">
                <label>91</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Singh</surname>
                            <given-names>K.</given-names>
                        </name>
                        <name>
                            <surname>Tiwary</surname>
                            <given-names>A.K.</given-names>
                        </name>
                        <name>
                            <surname>Rana</surname>
                            <given-names>V.</given-names>
                        </name>
                    </person-group>
                    <article-title>Spray dried chitosan-EDTA superior microparticles as solid substrate for the oral delivery of amphotericin B.</article-title>
                    <source>Int. J. Biol. Macromol.</source>
                    <year>2013</year>
                    <volume>58</volume>
                    <fpage>310</fpage>
                    <lpage>319</lpage>
                    <pub-id pub-id-type="doi">10.1016/j.ijbiomac.2013.04.053</pub-id> <pub-id pub-id-type="pmid"> 23624284</pub-id>
                </element-citation>
            </ref>
            <ref id="r92">
                <label>92</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Yang</surname>
                            <given-names>Z.</given-names>
                        </name>
                        <name>
                            <surname>Tan</surname>
                            <given-names>Y.</given-names>
                        </name>
                        <name>
                            <surname>Chen</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Dian</surname>
                            <given-names>L.</given-names>
                        </name>
                        <name>
                            <surname>Shan</surname>
                            <given-names>Z.</given-names>
                        </name>
                        <name>
                            <surname>Peng</surname>
                            <given-names>X.</given-names>
                        </name>
                        <name>
                            <surname>Wu</surname>
                            <given-names>C.</given-names>
                        </name>
                    </person-group>
                    <article-title>Development of amphotericin B-loaded cubosomes through the SolEmuls technology for enhancing the oral bioavailability.</article-title>
                    <source>AAPS PharmSciTech</source>
                    <year>2012</year>
                    <volume>13</volume>
                    <issue>4</issue>
                    <fpage>1483</fpage>
                    <lpage>1491</lpage>
                    <pub-id pub-id-type="doi">10.1208/s12249-012-9876-2</pub-id> <pub-id pub-id-type="pmid"> 23090113</pub-id>
                </element-citation>
            </ref>
            <ref id="r93">
                <label>93</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Prajapati</surname>
                            <given-names>V.K.</given-names>
                        </name>
                        <name>
                            <surname>Awasthi</surname>
                            <given-names>K.</given-names>
                        </name>
                        <name>
                            <surname>Yadav</surname>
                            <given-names>T.P.</given-names>
                        </name>
                        <name>
                            <surname>Rai</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Srivastava</surname>
                            <given-names>O.N.</given-names>
                        </name>
                        <name>
                            <surname>Sundar</surname>
                            <given-names>S.</given-names>
                        </name>
                    </person-group>
                    <article-title>An oral formulation of amphotericin B attached to functionalized carbon nanotubes is an effective treatment for experimental visceral leishmaniasis.</article-title>
                    <source>J. Infect. Dis.</source>
                    <year>2012</year>
                    <volume>205</volume>
                    <issue>2</issue>
                    <fpage>333</fpage>
                    <lpage>336</lpage>
                    <pub-id pub-id-type="doi">10.1093/infdis/jir735</pub-id> <pub-id pub-id-type="pmid"> 22158723</pub-id>
                </element-citation>
            </ref>
            <ref id="r94">
                <label>94</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Sun</surname>
                            <given-names>H.</given-names>
                        </name>
                        <name>
                            <surname>She</surname>
                            <given-names>P.</given-names>
                        </name>
                        <name>
                            <surname>Lu</surname>
                            <given-names>G.</given-names>
                        </name>
                        <name>
                            <surname>Xu</surname>
                            <given-names>K.</given-names>
                        </name>
                        <name>
                            <surname>Zhang</surname>
                            <given-names>W.</given-names>
                        </name>
                        <name>
                            <surname>Liu</surname>
                            <given-names>Z.</given-names>
                        </name>
                    </person-group>
                    <article-title>Recent advances in the development of functionalized carbon nanotubes: A versatile vector for drug delivery.</article-title>
                    <source>J. Mater. Sci.</source>
                    <year>2014</year>
                    <volume>49</volume>
                    <issue>20</issue>
                    <fpage>6845</fpage>
                    <lpage>6854</lpage>
                    <pub-id pub-id-type="doi">10.1007/s10853-014-8436-4</pub-id>
                </element-citation>
            </ref>
            <ref id="r95">
                <label>95</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Serrano</surname>
                            <given-names>D.R.</given-names>
                        </name>
                        <name>
                            <surname>Lalatsa</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Dea-Ayuela</surname>
                            <given-names>M.A.</given-names>
                        </name>
                        <name>
                            <surname>Bilbao-Ramos</surname>
                            <given-names>P.E.</given-names>
                        </name>
                        <name>
                            <surname>Garrett</surname>
                            <given-names>N.L.</given-names>
                        </name>
                        <name>
                            <surname>Moger</surname>
                            <given-names>J.</given-names>
                        </name>
                        <name>
                            <surname>Guarro</surname>
                            <given-names>J.</given-names>
                        </name>
                        <name>
                            <surname>Capilla</surname>
                            <given-names>J.</given-names>
                        </name>
                        <name>
                            <surname>Ballesteros</surname>
                            <given-names>M.P.</given-names>
                        </name>
                        <name>
                            <surname>Sch&#x00E4;tzlein</surname>
                            <given-names>A.G.</given-names>
                        </name>
                        <name>
                            <surname>Bol&#x00E1;s</surname>
                            <given-names>F.</given-names>
                        </name>
                        <name>
                            <surname>Torrado</surname>
                            <given-names>J.J.</given-names>
                        </name>
                        <name>
                            <surname>Uchegbu</surname>
                            <given-names>I.F.</given-names>
                        </name>
                    </person-group>
                    <article-title>Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles.</article-title>
                    <source>Mol. Pharm.</source>
                    <year>2015</year>
                    <volume>12</volume>
                    <issue>2</issue>
                    <fpage>420</fpage>
                    <lpage>431</lpage>
                    <pub-id pub-id-type="doi">10.1021/mp500527x</pub-id> <pub-id pub-id-type="pmid"> 25558881</pub-id>
                </element-citation>
            </ref>
            <ref id="r96">
                <label>96</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Delmas</surname>
                            <given-names>G.</given-names>
                        </name>
                        <name>
                            <surname>Park</surname>
                            <given-names>S.</given-names>
                        </name>
                        <name>
                            <surname>Chen</surname>
                            <given-names>Z.W.</given-names>
                        </name>
                        <name>
                            <surname>Tan</surname>
                            <given-names>F.</given-names>
                        </name>
                        <name>
                            <surname>Kashiwazaki</surname>
                            <given-names>R.</given-names>
                        </name>
                        <name>
                            <surname>Zarif</surname>
                            <given-names>L.</given-names>
                        </name>
                        <name>
                            <surname>Perlin</surname>
                            <given-names>D.S.</given-names>
                        </name>
                    </person-group>
                    <article-title>Efficacy of orally delivered cochleates containing amphotericin B in a murine model of aspergillosis.</article-title>
                    <source>Antimicrob. Agents Chemother.</source>
                    <year>2002</year>
                    <volume>46</volume>
                    <issue>8</issue>
                    <fpage>2704</fpage>
                    <lpage>2707</lpage>
                    <pub-id pub-id-type="doi">10.1128/AAC.46.8.2704-2707.2002</pub-id> <pub-id pub-id-type="pmid"> 12121962</pub-id>
                </element-citation>
            </ref>
            <ref id="r97">
                <label>97</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Zarif</surname>
                            <given-names>L.</given-names>
                        </name>
                        <name>
                            <surname>Graybill</surname>
                            <given-names>J.R.</given-names>
                        </name>
                        <name>
                            <surname>Perlin</surname>
                            <given-names>D.</given-names>
                        </name>
                        <name>
                            <surname>Mannino</surname>
                            <given-names>R.J.</given-names>
                        </name>
                    </person-group>
                    <article-title>Cochleates: New lipid-based drug delivery system.</article-title>
                    <source>J. Liposome Res.</source>
                    <year>2000</year>
                    <volume>10</volume>
                    <issue>4</issue>
                    <fpage>523</fpage>
                    <lpage>538</lpage>
                    <pub-id pub-id-type="doi">10.3109/08982100009031116</pub-id>
                </element-citation>
            </ref>
            <ref id="r98">
                <label>98</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Wasan</surname>
                            <given-names>K.M.</given-names>
                        </name>
                        <name>
                            <surname>Wasan</surname>
                            <given-names>E.K.</given-names>
                        </name>
                        <name>
                            <surname>Gershkovich</surname>
                            <given-names>P.</given-names>
                        </name>
                        <name>
                            <surname>Zhu</surname>
                            <given-names>X.</given-names>
                        </name>
                        <name>
                            <surname>Tidwell</surname>
                            <given-names>R.R.</given-names>
                        </name>
                        <name>
                            <surname>Werbovetz</surname>
                            <given-names>K.A.</given-names>
                        </name>
                        <name>
                            <surname>Clement</surname>
                            <given-names>J.G.</given-names>
                        </name>
                        <name>
                            <surname>Thornton</surname>
                            <given-names>S.J.</given-names>
                        </name>
                    </person-group>
                    <article-title>Highly effective oral amphotericin B formulation against murine visceral leishmaniasis.</article-title>
                    <source>J. Infect. Dis.</source>
                    <year>2009</year>
                    <volume>200</volume>
                    <issue>3</issue>
                    <fpage>357</fpage>
                    <lpage>360</lpage>
                    <pub-id pub-id-type="doi">10.1086/600105</pub-id> <pub-id pub-id-type="pmid"> 19545212</pub-id>
                </element-citation>
            </ref>
            <ref id="r99">
                <label>99</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Wasan</surname>
                            <given-names>E.K.</given-names>
                        </name>
                        <name>
                            <surname>Bartlett</surname>
                            <given-names>K.</given-names>
                        </name>
                        <name>
                            <surname>Gershkovich</surname>
                            <given-names>P.</given-names>
                        </name>
                        <name>
                            <surname>Sivak</surname>
                            <given-names>O.</given-names>
                        </name>
                        <name>
                            <surname>Banno</surname>
                            <given-names>B.</given-names>
                        </name>
                        <name>
                            <surname>Wong</surname>
                            <given-names>Z.</given-names>
                        </name>
                        <name>
                            <surname>Gagnon</surname>
                            <given-names>J.</given-names>
                        </name>
                        <name>
                            <surname>Gates</surname>
                            <given-names>B.</given-names>
                        </name>
                        <name>
                            <surname>Leon</surname>
                            <given-names>C.G.</given-names>
                        </name>
                        <name>
                            <surname>Wasan</surname>
                            <given-names>K.M.</given-names>
                        </name>
                    </person-group>
                    <article-title>Development and characterization of oral lipid-based amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans.</article-title>
                    <source>Int. J. Pharm.</source>
                    <year>2009</year>
                    <volume>372</volume>
                    <issue>1-2</issue>
                    <fpage>76</fpage>
                    <lpage>84</lpage>
                    <pub-id pub-id-type="doi">10.1016/j.ijpharm.2009.01.003</pub-id> <pub-id pub-id-type="pmid"> 19236839</pub-id>
                </element-citation>
            </ref>
            <ref id="r100">
                <label>100</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Wasan</surname>
                            <given-names>E.K.</given-names>
                        </name>
                        <name>
                            <surname>Gershkovich</surname>
                            <given-names>P.</given-names>
                        </name>
                        <name>
                            <surname>Zhao</surname>
                            <given-names>J.</given-names>
                        </name>
                        <name>
                            <surname>Zhu</surname>
                            <given-names>X.</given-names>
                        </name>
                        <name>
                            <surname>Werbovetz</surname>
                            <given-names>K.</given-names>
                        </name>
                        <name>
                            <surname>Tidwell</surname>
                            <given-names>R.R.</given-names>
                        </name>
                        <name>
                            <surname>Clement</surname>
                            <given-names>J.G.</given-names>
                        </name>
                        <name>
                            <surname>Thornton</surname>
                            <given-names>S.J.</given-names>
                        </name>
                        <name>
                            <surname>Wasan</surname>
                            <given-names>K.M.</given-names>
                        </name>
                    </person-group>
                    <article-title>A novel tropically stable oral amphotericin B formulation (iCo-010) exhibits efficacy against visceral Leishmaniasis in a murine model.</article-title>
                    <source>PLoS Negl. Trop. Dis.</source>
                    <year>2010</year>
                    <volume>4</volume>
                    <issue>12</issue>
                    <elocation-id>e913</elocation-id>
                    <pub-id pub-id-type="doi">10.1371/journal.pntd.0000913</pub-id> <pub-id pub-id-type="pmid"> 21151883</pub-id>
                </element-citation>
            </ref>
            <ref id="r101">
                <label>101</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Sivak</surname>
                            <given-names>O.</given-names>
                        </name>
                        <name>
                            <surname>Gershkovich</surname>
                            <given-names>P.</given-names>
                        </name>
                        <name>
                            <surname>Lin</surname>
                            <given-names>M.</given-names>
                        </name>
                        <name>
                            <surname>Wasan</surname>
                            <given-names>E.K.</given-names>
                        </name>
                        <name>
                            <surname>Zhao</surname>
                            <given-names>J.</given-names>
                        </name>
                        <name>
                            <surname>Owen</surname>
                            <given-names>D.</given-names>
                        </name>
                        <name>
                            <surname>Clement</surname>
                            <given-names>J.G.</given-names>
                        </name>
                        <name>
                            <surname>Wasan</surname>
                            <given-names>K.M.</given-names>
                        </name>
                    </person-group>
                    <article-title>Tropically stable novel oral lipid formulation of amphotericin B (iCo-010): Biodistribution and toxicity in a mouse model.</article-title>
                    <source>Lipids Health Dis.</source>
                    <year>2011</year>
                    <volume>10</volume>
                    <fpage>135</fpage>
                    <pub-id pub-id-type="doi">10.1186/1476-511X-10-135</pub-id> <pub-id pub-id-type="pmid"> 21824435</pub-id>
                </element-citation>
            </ref>
            <ref id="r102">
                <label>102</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Cao</surname>
                            <given-names>X.</given-names>
                        </name>
                        <name>
                            <surname>Rong</surname>
                            <given-names>C.</given-names>
                        </name>
                        <name>
                            <surname>Zhong</surname>
                            <given-names>A.</given-names>
                        </name>
                        <name>
                            <surname>Lu</surname>
                            <given-names>T.</given-names>
                        </name>
                        <name>
                            <surname>Liu</surname>
                            <given-names>S.</given-names>
                        </name>
                    </person-group>
                    <article-title>Molecular acidity: An accurate description with information-theoretic approach in density functional reactivity theory.</article-title>
                    <source>J. Comput. Chem.</source>
                    <year>2018</year>
                    <volume>39</volume>
                    <issue>2</issue>
                    <fpage>117</fpage>
                    <lpage>129</lpage>
                    <pub-id pub-id-type="doi">10.1002/jcc.25090</pub-id> <pub-id pub-id-type="pmid"> 29076175</pub-id>
                </element-citation>
            </ref>
            <ref id="r103">
                <label>103</label>
                <element-citation publication-type="journal">
                    <person-group person-group-type="author">
                        <name>
                            <surname>Saleem</surname>
                            <given-names>H.</given-names>
                        </name>
                        <name>
                            <surname>Thanikachalam</surname>
                            <given-names>V.</given-names>
                        </name>
                        <name>
                            <surname>Babu</surname>
                            <given-names>N.R.</given-names>
                        </name>
                        <name>
                            <surname>Bharanidharan</surname>
                            <given-names>S.</given-names>
                        </name>
                    </person-group>
                    <article-title>Vibrational spectroscopy (FT-IR, FT-Raman and UV) studies of E-[1-Methyl-2,6-Diphenyl- 3-(Propan-2-Yl)Piperidin-4-Ylidene] Amino 3-Methylbenzoate] using DFT method physics.</article-title>
                    <source>Int. J. Sci. Res.</source>
                    <year>2017</year>
                    <volume>2016</volume>
                    <issue>November</issue>
                </element-citation>
            </ref>
        </ref-list>
    </back>
</article>